Malignant neoplasm of colon

C3_COLON

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Cause of death: ICD-10 — C18 Cause of death: ICD-9 — 153 Cause of death: ICD-8 — 153 Cancer registry: Topography ICD-O-3 — C18 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 2 out of 7 registries used, show all original rules.	7915
4. Check minimum number of events None	7915
5. Include endpoints None	7915
6. Filter based on genotype QC (FinnGen only)	7095

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF9

NAME	C3_COLON
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C18
COD_ICD_9	153
COD_ICD_8	153
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C18
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of colon based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7095	3248	3847
Unadjusted period prevalence (%)	1.48	1.15	1.76
Median age at first event (years)	70.09	69.20	70.85

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7339: Matched controls
73376

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

321.2

306

JFF23

NOMESCO Finland

Transversostomy

28.9

310.9

208

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

10.9

310.5

340

327

WW500

NOMESCO Finland

Blood transfusion

7.9

308.6

435

580

Z51.5

ICD-10 Finland

Palliative care

8.9

307.7

1424

1940

JAL30

NOMESCO Finland

Omentectomy

37.7

307.7

223

ZXE20

NOMESCO Finland

More than three and less than five hours

3.4

307.7

1492

5160

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

307.7

941

A04AA01

ATC

ondansetron; systemic, rectal

11.8

307.7

926

887

WF002

NOMESCO Finland

Radical radiotherapy

61.0

307.7

310

L03AA02

ATC

filgrastim; parenteral

176.0

307.7

255

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

307.7

540

ZX120

NOMESCO Finland

Intravenous

4.1

307.7

985

2650

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

307.7

1341

PJA12

NOMESCO Finland

Sentinel node biopsy

842.9

307.7

323

C61

ICD-10 Finland

Malignant neoplasm of prostate

377.4

307.7

622

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

307.7

361

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

671.2

307.7

726

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.7

307.7

820

1896

JFB43

NOMESCO Finland

Left hemicolectomy

57.1

307.7

390

D75

ICPC

Malignant neoplasm colon/rectum

263.7

307.7

446

A04AA55

ATC

palonosetron, combinations; systemic

+∞

307.7

335

JFB30

NOMESCO Finland

Right hemicolectomy

129.3

307.7

1370

130

H02AB02

ATC

dexamethasone; systemic

73.3

307.7

2004

374

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

7.1

307.7

1618

2828

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

3256.0

307.7

322

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

+∞

307.7

309

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

307.7

815

B01AB10

ATC

tinzaparin; parenteral

5.4

307.7

1406

3079

JN3AD

NOMESCO Finland

Abdominal CT examination

3.8

307.7

1605

5053

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

204.4

307.7

736

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

307.7

1247

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

307.7

323

WX402

NOMESCO Finland

General anaesthesia

3.8

307.7

2147

7244

A79

ICPC

Malignancy NOS

114.9

307.7

223

Y77

ICPC

Malignant neoplasm prostate

172.9

307.7

169

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

16384.0

307.7

1915

UJF32

NOMESCO Finland

Coloscopy

8.7

307.7

4793

13033

XX3DW

NOMESCO Finland

Time consuming IT work

5.2

307.7

739

1541

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

1664.2

307.7

1125

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

5.3

307.7

782

1614

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

8.8

307.7

1141

1502

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

23.3

307.7

1104

553

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

45.2

307.7

215

JFB46

NOMESCO Finland

Resection of sigmoid colon

23.8

307.7

510

230

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

4.7

307.7

1068

2590

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

307.7

702

WZC00

NOMESCO Finland

Treatment plan or consultation

3.2

307.7

3040

13231

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

24.0

307.7

543

243

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

307.7

367

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.8

307.7

1210

3644

A04AA02

ATC

granisetron; systemic, transdermal

981.5

307.7

1669

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

307.7

351

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

8.1

307.7

699

943

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

106.5

307.7

197

JN4CD

NOMESCO Finland

Very extensive body CT

15.0

307.7

585

421

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

307.7

968

N02AA05

ATC

oxycodone; systemic

3.3

307.7

2035

7671

JAH00

NOMESCO Finland

Laparotomy

7.8

307.7

515

701

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

41.4

307.7

213

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

307.7

1004

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

+∞

307.7

420

L02BG04

ATC

letrozole; oral

35.5

307.7

234

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

+∞

307.7

473

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

307.7

440

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

692.8

307.7

747

B01AB05

ATC

enoxaparin; parenteral

4.9

307.7

4047

14750

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

11537.2

307.7

1009

116

Kela drug reimbursment

Prostate cancer

+∞

307.7

358

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

307.7

585

WZC30

NOMESCO Finland

Teaching

5.1

307.7

2057

5195

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

4832.1

307.7

464

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

48.8

307.7

389

WF049

NOMESCO Finland

Radiotherapy of metastasis

830.8

307.7

394

115

Kela drug reimbursment

Breast cancer

+∞

307.7

316

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

39.8

307.7

968

279

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

2560.1

307.7

943

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

307.7

756

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

307.7

389

JN4AD

NOMESCO Finland

Body CT examination

12.6

307.7

2246

2477

WX408

NOMESCO Finland

General anesthesy, balanced

3.5

307.7

2562

9824

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

306.0

307.7

1678

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

10625.4

307.7

940

TPH07

NOMESCO Finland

Cathetrisation of artery

4.8

307.7

1756

4480

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

2156.8

307.7

626

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

307.7

365

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

151.1

307.7

332

JN4BD

NOMESCO Finland

Extensive body CT

17.1

307.7

2107

1692

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

7.9

307.7

712

981

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

3389

JN3BD

NOMESCO Finland

Extensive abdominal CT

4.1

307.7

1202

3320

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

8299.8

307.7

1379

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

4606.2

307.7

444

L02AE02

ATC

leuprorelin; implant, parenteral

48.5

307.7

253

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

446.1

307.7

383

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

198.7

307.7

448

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

307.7

1911

TPX10

NOMESCO Finland

Implantation of vascular injection port

10.8

307.7

544

540

WX302

NOMESCO Finland

Thoracal epidural anesthesy

29.3

307.7

1564

671

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

307.7

338

L01BC06

ATC

capecitabine; oral

+∞

307.7

2544

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

+∞

307.7

446

A03FA01

ATC

metoclopramide; systemic, rectal

12.3

307.7

3371

4753

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

307.7

461

JFB54

NOMESCO Finland

Laparoscopic resection of sigmoid colon with partial proctectomy

122.6

307.6

156

C18.51

ICD-10 Finland

Malignant tumor of flexura hiealis invasive carcinoma

+∞

301.1

287

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

297.9

284

L01BC59

ATC

trifluridine, combinations; systemic

+∞

295.8

282

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

8.7

294.0

381

459

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

287.4

274

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

2748.5

286.0

275

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

284.2

271

L03AA13

ATC

pegfilgrastim; parenteral

1441.8

283.9

275

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

23.5

283.1

204

JFF10

NOMESCO Finland

Loop enterostomy

45.9

282.2

166

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

282.1

269

TJF80

NOMESCO Finland

Ostomy education

23.2

272.1

197

JFB00

NOMESCO Finland

Partial resection of small intestine

9.6

271.6

325

353

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

43.6

265.5

158

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

23.3

264.2

191

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

264.1

252

ZX090

NOMESCO Finland

Other technic of radiotherapy

121.2

257.9

131

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

255.7

244

D64.9

ICD-10 Finland

Anaemia, unspecified

2.9

254.4

1467

5858

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

631.6

248.7

245

C18.10

ICD-10 Finland

Malignant tumor of the appendix without histology

+∞

245.2

234

C18.19

ICD-10 Finland

Malignant tumor in appendix other or unspecified histology

+∞

243.0

232

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

243.0

232

C18.22

ICD-10 Finland

Malignant tumor of the colon ascending carcinoma of the adenoma

+∞

243.0

232

JFB50

NOMESCO Finland

Other resection of colon

41.4

242.2

146

JAH01

NOMESCO Finland

Laparoscopy

5.6

241.3

473

885

8140/3-C18.6

ICD-O-3

Adenocarcinoma, NOS, of descending colon

+∞

240.9

230

HAB40

NOMESCO Finland

Wedge excision of mammary gland

20.4

239.4

183

A04AD12

ATC

aprepitant; systemic

1196.5

238.7

232

JFH00

NOMESCO Finland

Total colectomy and ileorectal anastomosis

46.0

238.2

140

8140/3-C18.3

ICD-O-3

Adenocarcinoma, NOS, of hepatic flexure of colon

+∞

237.8

227

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

72.3

236.8

128

C18.02

ICD-10 Finland

Malignant tumor of caecum carcinoma of adenoma

+∞

236.7

226

C18.9

ICD-10 Finland

Malignant neoplasm: Colon, unspecified

+∞

226.2

216

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

4.7

225.5

543

1214

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

2026.4

214.4

207

C18.50

ICD-10 Finland

Malignant tumor in flexural lienalis without histology

+∞

213.6

204

K56.7

ICD-10 Finland

Ileus, unspecified

6.9

211.7

333

500

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

9.5

209.5

250

270

JFB40

NOMESCO Finland

Resection of transverse colon

108.5

208.2

107

176

Kela drug reimbursment

Regorafenib

+∞

205.1

196

Z31.5

ICD-10 Finland

Genetic counselling

5.9

203.8

380

677

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

203.7

1976

10007

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

105.5

201.8

104

Z93.3

ICD-10 Finland

Colostomy status

21.2

200.0

150

369

Kela drug reimbursment

Regorafenib

+∞

193.6

185

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

11.9

192.9

197

170

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

4.7

191.8

459

1019

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

188.3

180

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

15.1

185.4

164

111

C18.4

ICD-10 Finland

Malignant neoplasm: Transverse colon

+∞

185.2

177

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

185.2

177

C18

ICD-10 Finland

Malignant neoplasm of colon

+∞

184.1

176

C18.91

ICD-10 Finland

Malignant tumor of unspecified location in colon invasive carcinoma

+∞

184.1

176

8240/3-C18.1

ICD-O-3

Neuroendocrine tumor, NOS, of appendix

+∞

183.1

175

L02BA01

ATC

tamoxifen; oral

60.2

181.2

101

NK6AN

NOMESCO Finland

Total body bone isotope imaging

28.2

181.1

122

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

8.4

180.5

237

289

WX600

NOMESCO Finland

Single shot through catheter

14.1

178.4

164

119

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

6.4

178.1

300

483

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

14.6

176.7

159

111

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

4.3

176.2

484

1196

C18.1

ICD-10 Finland

Malignant neoplasm: Appendix

+∞

175.7

168

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

3.3

174.8

706

2271

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

6.5

173.5

289

460

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

3.9

168.8

528

1434

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

35.5

167.3

105

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

424.6

167.3

167

UJF30

NOMESCO Finland

Ileoscopy through colon

2.7

166.8

1010

4073

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

5.4

162.5

328

628

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.4

161.0

1370

6479

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

86.0

160.9

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.9

160.7

813

2978

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

19.0

158.7

125

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

20.7

158.3

120

WF004

NOMESCO Finland

Palliative radiotherapy

790.1

158.0

155

8240/3-C18.2

ICD-O-3

Neuroendocrine tumor, NOS, of ascending colon

+∞

156.8

150

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

5.8

156.5

295

530

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

66.1

154.9

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

764.0

152.8

150

8480/3-C18.1

ICD-O-3

Mucinous adenocarcinoma of appendix

+∞

152.6

146

D37.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Appendix

27.9

151.0

102

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

43.4

151.0

ZXE10

NOMESCO Finland

More than one and less than three hours

1.9

150.8

2718

17041

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

4.4

150.5

394

937

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

5.1

149.8

325

663

JFF13

NOMESCO Finland

Terminal enterostomy

27.2

149.6

102

WF003

NOMESCO Finland

Adjuvant radiotherapy

196.5

148.3

154

8140/3-C18.5

ICD-O-3

Adenocarcinoma, NOS, of splenic flexure of colon

+∞

146.3

140

8480/3-C18.0

ICD-O-3

Mucinous adenocarcinoma of cecum

+∞

144.2

138

L02BB03

ATC

bicalutamide; oral

1434.6

143.2

139

WX704

NOMESCO Finland

Intubation

2.9

139.2

729

2713

JWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery

35.2

138.3

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

691.1

138.2

136

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

5.1

138.0

294

590

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.7

136.9

464

1328

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

4.3

136.9

366

884

D70.82

ICD-10 Finland

Drug-induced neutropenia

17.1

136.7

113

JJB10

NOMESCO Finland

Atypcal resection of liver

1349.9

135.8

132

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

1349.9

135.8

132

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.6

134.7

460

1323

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

134.5

2661

17049

HAC20

NOMESCO Finland

Total mastectomy

158.5

132.8

140

1XC07, ,

NOMESCO Finland

+∞

132.7

127

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.7

132.3

318

706

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

131.9

3821

27470

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

6.3

131.1

222

359

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

130.6

125

KCD02

NOMESCO Finland

Transurethral resection of bladder

11.6

130.1

134

117

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

129.5

124

C18.6

ICD-10 Finland

Malignant neoplasm: Descending colon

+∞

129.5

124

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.4

129.1

483

1474

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

11.8

129.1

132

114

HA1AA

NOMESCO Finland

X-ray mammography

4.2

128.3

353

871

A02BC02

ATC

pantoprazole; systemic

1.9

127.5

5094

40186

A06AH03

ATC

naloxegol; oral

11.4

127.1

133

119

JFB33

NOMESCO Finland

Other resection comprising small intestine and colon

31.9

126.6

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

1249.7

126.4

123

C18.3

ICD-10 Finland

Malignant neoplasm: Hepatic flexure

1239.3

125.4

122

UJF34

NOMESCO Finland

Left colonoscopy

10.1

124.2

141

142

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

123.7

2439

15517

6404

FHL

Hemicolectomy on the right

33.3

123.5

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

12.5

123.2

121

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

215.3

123.1

127

B01AB04

ATC

dalteparin; parenteral

3.2

122.8

512

1670

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.5

122.7

880

3822

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

7.4

122.2

178

245

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

5.9

120.6

221

386

WZC15, ,

NOMESCO Finland

29.6

119.1

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

20.2

117.7

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

36.8

117.5

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.3

117.2

1052

5035

8480/3-C18.2

ICD-O-3

Mucinous adenocarcinoma of ascending colon

+∞

117.0

112

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

117.0

112

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.3

116.1

1052

5054

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

58.7

114.1

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

566.7

113.2

112

N02BE01

ATC

paracetamol; systemic, rectal

2.3

111.4

6499

56626

E0000UV, ,

ATC

1.7

110.6

3002

20823

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

229.4

110.0

113

C18.39

ICD-10 Finland

Malignant tumor of flexura hepatica other or unspecified histology

+∞

109.6

105

C18.42

ICD-10 Finland

Malignant tumor of the transverse colon carcinoma of the adenoma

+∞

109.6

105

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

17.2

109.1

JG1BG

NOMESCO Finland

MRI of rectum

37.5

108.3

TPX15

NOMESCO Finland

Removal of vascular injection port

21.8

108.1

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

6.6

107.7

175

271

JMA10

NOMESCO Finland

Transabdominal total splenectomy

21.3

106.9

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

45.4

106.6

ZXC96

NOMESCO Finland

Robot assisted procedure

10.5

106.1

117

113

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

530.5

106.0

105

JFB20

NOMESCO Finland

Ileocaecal resection

14.9

105.8

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

104.4

100

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

104.4

100

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

54.1

103.5

C18.49

ICD-10 Finland

Malignant tumor of the transverse colon other or unspecified histology

+∞

102.3

R4190

NOMESCO Finland

Nutritional therapy

4.4

101.8

265

626

JKA20

NOMESCO Finland

Cholecystectomy

3.7

101.6

338

953

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

52.2

99.3

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

12.1

97.7

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

51.3

97.2

C18.62

ICD-10 Finland

Malignant tumor of the descending colon carcinoma of the adenoma

+∞

97.1

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

22.4

96.9

Z85.0

ICD-10 Finland

Personal history of malignant neoplasm of digestive organs

18.5

96.8

R4110

NOMESCO Finland

Physiotherapy

1.8

96.1

2004

12777

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

95.0

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

93.9

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

92.9

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

4.5

92.8

231

527

8480/3-C18.7

ICD-O-3

Mucinous adenocarcinoma of sigmoid colon

+∞

91.8

D77

ICPC

Malignant digestive neopl other/NOS

162.1

91.3

ZX121

NOMESCO Finland

Central venous catheter

30.2

91.1

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

453.3

90.4

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

89.8

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

448.1

89.4

L01XE21

ATC

[U] regorafenib

+∞

88.7

JN6AD

NOMESCO Finland

CT of torso and neck

8.5

87.9

113

134

C18.5

ICD-10 Finland

Malignant neoplasm: Splenic flexure

+∞

87.7

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.7

87.3

284

788

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.0

87.3

411

1434

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

858.5

86.8

L01EX05

ATC

regorafenib; oral

+∞

85.6

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

85.6

ZX080

NOMESCO Finland

Image guided radiotherapy

427.5

85.2

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

4.3

84.2

224

538

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

9.4

83.6

100

108

C187, 8148, 2

ICD-O-3

34.9

82.3

XX2RW, ,

NOMESCO Finland

8.1

82.2

110

137

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

5.7

81.8

154

276

C50.99

ICD-10 Finland

Breast, unspecified

281.1

81.7

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

807.3

81.6

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

81.4

ZX050

NOMESCO Finland

Stereotactic radiotherapy

31.4

81.3

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

12.4

81.2

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

12.7

81.1

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

4.6

81.0

194

429

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

8.3

80.7

106

129

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.8

80.7

149

262

UJG02

NOMESCO Finland

Proctoscopy

4.1

80.5

229

578

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

209.8

80.4

K92.1

ICD-10 Finland

Melaena

2.4

79.0

564

2426

R18

ICD-10 Finland

Ascites

4.8

78.7

180

383

L01BC53

ATC

tegafur, combinations; systemic

+∞

78.2

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

4.8

77.8

178

379

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

20.5

77.6

V03AF03

ATC

calcium folinate; systemic

766.4

77.4

C18.12

ICD-10 Finland

Malignant tumor of the appendix carcinoma of the adenoma

+∞

77.2

Z43.2

ICD-10 Finland

Attention to ileostomy

39.4

76.8

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

76.6

4520

36830

SPAT1125

SPAT

Stoma care and guidance

4.1

76.4

211

521

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.7

76.0

433

1670

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

75.4

1462

9034

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

9.3

74.8

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.5

74.6

500

2088

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

18.6

74.3

C18.69

ICD-10 Finland

Malignant tumor of colon descendens other or unspecified histology

+∞

74.1

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

4.3

73.4

192

455

K65.0

ICD-10 Finland

Acute peritonitis

5.1

73.4

156

312

JJB71

NOMESCO Finland

Laparoscopic resection of liver

725.5

73.3

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

73.3

2574

18544

JJB50

NOMESCO Finland

Excision of segments V, VI, VII and VIII of liver

191.9

73.3

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

6.7

73.2

117

178

C18.59

ICD-10 Finland

Malignant tumor in flexura lienalis other or unspecified histology

+∞

73.0

ZXD05

NOMESCO Finland

Urgent procedure

1.6

72.5

2133

14712

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

9.3

72.1

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

72.0

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.8

71.8

373

1371

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

705.1

71.2

ZZR00

NOMESCO Finland

Flap of skin

7.7

71.2

100

132

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

70.9

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.9

70.9

348

1241

R50.9

ICD-10 Finland

Fever, unspecified

1.9

70.6

1033

5844

SPAT1153

SPAT

Removal of sutures

1.6

70.3

2204

15417

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

30.8

70.1

JFG36

NOMESCO Finland

Closure of terminal colostomy with anastomosis to rectum

21.8

70.1

JFB51

NOMESCO Finland

Other laparoscopic resection of colon

126.3

70.0

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

69.9

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

69.9

C18.32

ICD-10 Finland

Malignant tumor of flexura hepatica carcinoma of adenoma

+∞

69.9

JFH10

NOMESCO Finland

Total colectomy and ileostomy

14.9

69.9

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

68.8

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

68.8

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

7.9

68.3

121

JEA01

NOMESCO Finland

Laparoscopic appendectomy

3.4

68.3

256

779

C18.81

ICD-10 Finland

Malignant overall tumor of the colon invasive carcinoma

+∞

67.8

TQW99

NOMESCO Finland

Other minor procedure on skin

2.9

67.2

325

1149

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

10.7

67.1

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

65.7

C50

ICD-10 Finland

Malignant neoplasm of breast

221.9

64.2

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

221.9

64.2

JFA42

NOMESCO Finland

Endoscopic injection in colon

8.7

64.1

8480/3-C18.9

ICD-O-3

Mucinous adenocarcinoma of colon, NOS

+∞

63.6

JEA00

NOMESCO Finland

Appendectomy

2.6

63.6

393

1577

ZX070

NOMESCO Finland

Intensity modified radiotherapy

166.4

63.0

JFB53

NOMESCO Finland

Resection of sigmoid colon with partial proctectomy

88.4

63.0

JN3GE

NOMESCO Finland

Intraoperative ultrasound examination of abdomen

623.5

62.9

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

623.5

62.9

8000/3-C18.9

ICD-O-3

Neoplasm, malignant of colon, NOS

+∞

62.6

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

62.6

Z93.2

ICD-10 Finland

Ileostomy status

10.9

62.5

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

87.1

62.0

B80

ICPC

Iron deficiency anaemia

3.3

61.9

245

771

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

16.4

61.6

8140/3-C18.1

ICD-O-3

Adenocarcinoma, NOS, of appendix

+∞

61.5

S18

ICPC

Laceration/cut

1.5

61.5

3254

25372

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

25.4

61.5

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

6.3

61.0

103

166

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

60.5

KC1GB

NOMESCO Finland

Cystography with X-ray

17.6

60.1

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

14.8

59.6

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

59.4

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.3

58.9

469

2111

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

15.6

58.8

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

11.6

58.4

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

57.4

Z3231

NOMESCO Finland

Registered nurse

1.6

57.1

1819

12656

Z51.0

ICD-10 Finland

Radiotherapy session

198.2

57.1

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

14.7

57.0

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.5

56.8

386

1619

JFF30

NOMESCO Finland

Other colostomy

22.9

56.3

8140/3-C18.8

ICD-O-3

Adenocarcinoma, NOS, of overlapping lesion of colon

+∞

56.3

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

9.4

56.2

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

17.1

55.7

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

55.3

ZX112

NOMESCO Finland

Subcutaneous

6.0

54.3

162

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

3.8

54.3

169

455

8480/3-C18.4

ICD-O-3

Mucinous adenocarcinoma of transverse colon

+∞

54.2

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.3

53.9

138

322

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

21.2

53.2

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

14.2

52.7

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.8

52.6

278

1030

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

521.7

52.5

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

521.7

52.5

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

6.8

52.4

122

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

52.1

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

52.1

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

138.5

51.9

J01MA12

ATC

levofloxacin; systemic

1.6

51.4

1291

8456

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.6

51.3

298

1159

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

51.1

JFA70

NOMESCO Finland

Suture of small intestine

10.2

51.0

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

3.1

50.7

215

705

LAE10

NOMESCO Finland

Unilateral oophorectomy

11.9

50.5

GD1AD

NOMESCO Finland

Thorax CT examination

2.2

50.3

445

2089

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

3.7

50.3

159

433

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

50.0

C18.52

ICD-10 Finland

Malignant tumor of flexura lienalis carcinoma of adenoma

+∞

50.0

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

50.0

C18.80

ICD-10 Finland

Malignant overall tumor of the colon without histology

+∞

50.0

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

50.0

223

753

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.7

49.6

270

1016

3AC01, ,

NOMESCO Finland

4.9

49.5

109

225

Z93

ICD-10 Finland

Artificial opening status

20.1

49.4

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

5.4

49.4

181

6434

FHL

Anterior resection

20.7

48.7

128

Kela drug reimbursment

Cancers of female genital organs

481.0

48.4

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

48.0

JJB30

NOMESCO Finland

Excision of two segments of liver

167.8

47.9

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

4.3

47.8

123

288

S77

ICPC

Malignant neoplasm of skin

14.4

47.6

JJB60

NOMESCO Finland

Other excsion of three or more segments of liver

470.8

47.4

C20

ICD-10 Finland

Malignant neoplasm of rectum

470.8

47.4

L02BG03

ATC

anastrozole; oral

76.4

47.0

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

46.9

178

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

+∞

46.9

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

46.9

JJA20

NOMESCO Finland

Open biopsy of liver

13.4

46.8

WX002

NOMESCO Finland

Sedation and analgesia

1.6

46.7

1348

9108

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

4.5

46.5

115

261

C187, 8211, 2

ICD-O-3

18.6

46.5

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

460.7

46.3

8480/1-C18.1

ICD-O-3

Low grade appendiceal mucinous neoplasm of appendix

66.6

46.1

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

45.9

C79.6

ICD-10 Finland

Secondary malignant neoplasm of ovary

+∞

45.9

L02BX02

ATC

degarelix; parenteral

+∞

45.9

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

45.9

C26.0

ICD-10 Finland

Malignant neoplasm: Intestinal tract, part unspecified

+∞

45.9

D99

ICPC

Disease digestive system other

4.8

45.6

104

221

K35.9

ICD-10 Finland

Acute appendicitis, unspecified

2.2

45.2

397

1857

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

98.7

44.8

K83.1

ICD-10 Finland

Obstruction of bile duct

4.7

44.7

103

221

KAC10

NOMESCO Finland

Total nephrectomy with capsule

18.1

44.7

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

18.1

44.7

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

44.6

549

2911

JG1CG

NOMESCO Finland

Extensive MRI of rectum

16.9

44.4

K56.0

ICD-10 Finland

Paralytic ileus

4.1

44.4

123

305

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

226.3

44.0

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

43.8

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

43.8

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

8.6

43.4

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

430.2

43.2

HAB99

NOMESCO Finland

Other partial excision of mammary gland

5.7

42.8

139

WX725

NOMESCO Finland

Noninvasive ventilation

2.2

42.8

390

1852

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

42.7

3049, ,

Kela drug reimbursment

+∞

42.7

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

42.7

1533A

ICD-9 Finland

Malignant neoplasm of colon, Sigmoid colon[NEOPL MALIG COLI SIGM,INVASIIVINEN KARSINOOMA]

+∞

42.7

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

55.9

42.4

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

55.9

42.4

SPAT1109

SPAT

Analgesia with portable analgesic pump

7.1

42.3

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

4.2

42.1

111

265

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

42.0

850

5243

XJA00

NOMESCO Finland

Intraoperative abdominal ultrasonography

216.2

41.9

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

16.7

41.8

JFC10

NOMESCO Finland

Ileotransversostomy

147.5

41.8

X76

ICPC

Malignant neoplasm breast female

113.2

41.7

8243/3-C18.1

ICD-O-3

Goblet cell carcinoid of appendix

+∞

41.7

JAQ10

NOMESCO Finland

Intraoperative hypertermic chemotherapeutic perfusion of abdominal cavity

+∞

41.7

L57.0

ICD-10 Finland

Actinic keratosis

1.8

41.7

689

4012

B82

ICPC

Anaemia other/unspecified

2.5

40.5

268

1109

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

40.4

515

2762

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

399.7

40.1

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

16.3

40.0

WX290

NOMESCO Finland

Other blockage of nerve

1.4

39.8

2426

18965

UJF32, ,

SPAT

2.4

39.8

269

1125

N02AX02

ATC

tramadol; systemic, rectal

1.4

39.7

2856

22969

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

39.6

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

39.6

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

39.6

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

9.1

39.5

R11

ICD-10 Finland

Nausea and vomiting

1.8

39.2

598

3396

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

8.5

39.0

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

86.6

38.8

L02AE04

ATC

triptorelin; parenteral

137.4

38.7

L01EC03

ATC

encorafenib; oral

+∞

38.6

1534A

ICD-9 Finland

Malignant neoplasm of colon, Caecum[NEOPL MALIG CAECI,INVASIIVINEN KARSINOOMA]

+∞

38.6

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

+∞

38.6

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

38.0

486

2609

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

37.5

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

37.5

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

37.5

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

37.5

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

37.5

JAL00

NOMESCO Finland

Biopsy of peritoneum

12.4

37.5

JFF26

NOMESCO Finland

Sigmoidostomy

14.2

37.3

WGA11

NOMESCO Finland

Planning of pain management

7.5

37.3

K63.5

ICD-10 Finland

Polyp of colon

2.7

37.2

203

765

L02BG06

ATC

exemestane; oral

369.2

37.0

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.8

37.0

115

310

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.2

36.8

339

1615

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

190.9

36.8

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

190.9

36.8

D48.42

ICD-10 Finland

Tumor of uncertain or unknown nature in the peritoneum originating in the appendix

190.9

36.8

KCD10

NOMESCO Finland

Partial cystectomy

49.1

36.6

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

36.5

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

54.0

36.3

Z3226

NOMESCO Finland

Physiotherapist

1.5

36.2

1138

7794

D39.10

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary without histology

3.3

36.1

138

426

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

359.1

36.0

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

3.3

35.8

136

418

JWW96

NOMESCO Finland

Other reoperation in gastroenterological surgery

12.6

35.7

WPB10

NOMESCO Finland

Making a convalescent care decision

9.8

35.6

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.3

35.5

262

1139

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

35.4

WPA16

NOMESCO Finland

Extensive demanding palliative symptom assessment and treatment

58.9

35.2

Y83.2

ICD-10 Finland

Surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

7.6

34.8

Z2221

NOMESCO Finland

Medical doctor

1.4

34.7

1599

11827

LCD00

NOMESCO Finland

Hysterectomy

2.4

34.6

247

1059

UKC02

NOMESCO Finland

Cystoscopy

1.5

34.5

1130

7800

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

34.4

C18.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of colon

+∞

34.4

8480/3-C18.3

ICD-O-3

Mucinous adenocarcinoma of hepatic flexure of colon

+∞

34.4

C90.0

ICD-10 Finland

Multiple myeloma

+∞

34.4

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

34.4

1526, ,

Kela drug reimbursment

+∞

34.4

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

10.3

34.2

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.9

34.1

101

263

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

34.0

1094

7522

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

65.3

34.0

H01CB03

ATC

lanreotide; parenteral

65.3

34.0

D50

ICD-10 Finland

Iron deficiency anaemia

2.8

33.9

171

619

SPAT1088

SPAT

Blood transfusion

6.3

33.7

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.3

33.4

257

1138

L02BB04

ATC

enzalutamide; oral

+∞

33.3

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

33.3

C17.2

ICD-10 Finland

Malignant neoplasm: Ileum

+∞

33.3

JJB20

NOMESCO Finland

Excision of single segment of liver

+∞

33.3

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

33.3

WX882

NOMESCO Finland

High dependency care

2.5

33.3

210

850

ZXE00

NOMESCO Finland

One hour or less

1.4

33.1

2312

18354

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

4.8

33.1

155

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

32.9

546

3175

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

117.2

32.7

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

7.6

32.6

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.5

32.6

204

823

K35.1

ICD-10 Finland

Acute appendicitis with peritoneal abscess

3.9

32.5

250

J01MA02

ATC

ciprofloxacin; systemic

1.4

32.4

2632

21387

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

32.3

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

32.3

E34.0

ICD-10 Finland

Carcinoid syndrome

61.9

32.0

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

113.9

31.7

JFK10

NOMESCO Finland

Freeing of adhesions in intestinal obstruction

6.5

31.5

ZX100

NOMESCO Finland

Oral

3.6

31.4

104

293

1XC08, ,

NOMESCO Finland

+∞

31.3

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

31.3

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

31.3

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

3.5

31.1

106

304

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

11.0

31.1

P01AB01

ATC

metronidazole; oral, rectal

1.4

31.0

2327

18640

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.9

31.0

236

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

30.9

177

684

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.8

30.9

154

554

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

4.0

30.8

219

ZXC20

NOMESCO Finland

Use of chemical agents

3.2

30.4

118

368

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

30.2

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

30.2

8210/3-C18.7

ICD-O-3

Adenocarcinoma in adenomatous polyp of sigmoid colon

+∞

30.2

JFB41

NOMESCO Finland

Laparoscopic resection of transverse colon

58.6

30.1

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

30.0

322

1625

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

3.3

29.9

112

342

JN4DD

NOMESCO Finland

Scout CT scan of torso

107.1

29.7

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

34.7

29.6

Y83.6

ICD-10 Finland

Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

9.8

29.4

D12.1

ICD-10 Finland

Benign neoplasm: Appendix

6.9

29.2

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

29.1

473

2734

H01CB02

ATC

octreotide; parenteral

40.2

28.9

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

66.2

28.9

TQW20

NOMESCO Finland

Tatoe

33.8

28.7

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

150.6

28.6

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

150.6

28.6

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

8.1

28.6

TJX90

NOMESCO Finland

Other minor procedure in gastroenterological surgery

9.0

28.6

D64.8

ICD-10 Finland

Other specified anaemias

2.6

28.3

164

638

WX892

NOMESCO Finland

Monitored bed care

1.7

28.3

530

3189

SPAT1255

SPAT

Intravenous administration of medicine

1.8

28.1

472

2752

L01CB01

ATC

etoposide; systemic

+∞

28.1

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

28.1

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

282.6

27.8

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

145.5

27.6

JAD10

NOMESCO Finland

Repair of incisional hernia

4.2

27.6

171

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

28.6

27.5

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

27.5

1411

10580

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

2.9

27.4

129

450

KAD00

NOMESCO Finland

Partial nephrectomy

10.0

27.4

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

3.5

27.3

267

L02BX03

ATC

abiraterone; oral

+∞

27.1

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

27.1

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

5.4

27.0

XW000

NOMESCO Finland

Bone marrow biopsy

2.4

26.8

182

763

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.8

26.7

137

501

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.6

26.6

157

616

ZXC15

NOMESCO Finland

Use of photodynamic technique

3.8

26.6

211

JGB04

NOMESCO Finland

Laparoscopic partial proctectomy with partial excision of mesorectum

45.9

26.4

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

7.9

26.4

L02AE03

ATC

goserelin; implant

7.9

26.4

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

26.0

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

26.0

C18.89

ICD-10 Finland

Malignant overall tumor of the colon other or unspecified histology

+∞

26.0

C18.82

ICD-10 Finland

Malignant overall tumor of colon carcinoma of adenoma

+∞

26.0

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

26.0

JK3BT

NOMESCO Finland

Catherisation of bile duct with X-ray guidance

8.0

26.0

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

3.5

25.9

262

C82.1

ICD-10 Finland

Follicular lymphoma grade II

261.5

25.7

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

93.7

25.6

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

93.7

25.6

XX9TB

NOMESCO Finland

Complementary X-ray examination with contrast

9.2

25.6

WPA13

NOMESCO Finland

Palliative consultation

6.4

25.6

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

7.8

25.5

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

3.9

25.4

191

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

25.4

625

4030

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

25.4

1149

8415

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.0

25.2

110

368

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

25.2

237

1139

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

25.1

773

5243

1536A

ICD-9 Finland

Malignant neoplasm of colon, Ascending colon[NEOPL MALIG COLI ASCENDENTIS,INVASIIVINEN KARSINOOM]

+∞

25.0

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

25.0

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

25.0

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

25.0

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

+∞

25.0

B03XA02

ATC

darbepoetin alfa; parenteral

2.8

24.9

126

458

J01DB01

ATC

cefalexin; oral

1.3

24.8

5305

48617

D01.0

ICD-10 Finland

Carcinoma in situ: Colon

70.1

24.8

Z43.3

ICD-10 Finland

Attention to colostomy

21.3

24.7

KBV10

NOMESCO Finland

Removal of stent from ureter

4.5

24.7

135

YX9AW, ,

NOMESCO Finland

251.0

24.7

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

7.8

24.6

JN7AQ

NOMESCO Finland

Somatostatin receptor SPET med low dose CT

130.4

24.6

ZQZ00

NOMESCO Finland

Treatment of several skin areas

8.6

24.5

ZXC40

NOMESCO Finland

Use of ultrasound

6.1

24.5

SPAT1131

SPAT

Colonoscopy

2.1

24.3

228

1096

C189, 8148, 2

ICD-O-3

48.5

24.2

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.9

24.2

116

409

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.8

24.2

120

431

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.1

24.2

239

1171

JWE00

NOMESCO Finland

Reoperation for deep haemorrhage in gastroenterological surgery

6.9

24.1

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.0

24.1

263

1336

ZXC50

NOMESCO Finland

Cryotherapy

2.4

24.1

162

677

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

4.1

24.1

163

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

3.2

24.1

305

N02AA01

ATC

morphine; systemic, rectal

2.7

24.0

126

467

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

8.4

24.0

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

23.9

755

5149

XKD00

NOMESCO Finland

Uroflowmetry

1.4

23.8

1030

7471

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

23.7

410

2412

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

240.7

23.6

XX1XN

NOMESCO Finland

Other isotope examination

240.7

23.6

XX1AD

NOMESCO Finland

Other CT-examination

41.5

23.6

JFH96

NOMESCO Finland

Other total colectomy

41.5

23.6

DAB10

NOMESCO Finland

Partial excision of auricle

41.5

23.6

TJA10

NOMESCO Finland

Laparocentesis

26.8

23.5

R86.0

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of enzymes

3.0

23.5

102

341

UJK02

NOMESCO Finland

ERCP

2.3

23.4

184

823

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

46.8

23.3

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

2.8

23.1

116

420

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

22.9

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

22.9

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

22.9

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

22.9

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

22.9

8244/3-C18.1

ICD-O-3

Mixed adenoneuroendocrine carcinoma of appendix

+∞

22.9

KA3EB

NOMESCO Finland

Antegrade pyelography

6.9

22.9

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

7.4

22.9

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

83.7

22.7

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

230.6

22.6

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

230.6

22.6

JFB63

NOMESCO Finland

Other resection of colon with proximal colostomy and closure of distal stump

25.9

22.6

A06AD11

ATC

lactulose; oral

1.4

22.5

1114

8274

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.6

22.2

129

503

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.7

22.2

122

463

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

52.2

22.1

JFC20

NOMESCO Finland

Other enterocolostomy

52.2

22.1

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

52.2

22.1

JF2AB

NOMESCO Finland

Colongraphy with X-ray

9.0

22.1

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

35.1

22.0

D16

ICPC

Rectal bleeding

2.3

21.9

168

744

PC2ET

NOMESCO Finland

Extensive embolisation of lesion of liver

+∞

21.9

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

21.9

L01BC04

ATC

carmofur; oral

+∞

21.9

C189, 8211, 2

ICD-O-3

18.4

21.7

D48.49

ICD-10 Finland

Tumor of uncertain or unknown nature in the peritoneum, of unknown origin

80.3

21.7

C44.22

ICD-10 Finland

Spinocellular carcinoma of the skin of the outer ear and the outer ear canal

80.3

21.7

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

115.4

21.6

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

115.4

21.6

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

115.4

21.6

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

115.4

21.6

KH1AA

NOMESCO Finland

Urinary tract X-ray examination without contrast

3.0

21.5

310

DHB00

NOMESCO Finland

Excision of lesion of external nose

6.4

21.3

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.5

21.3

211

JFB96

NOMESCO Finland

Other partial excision of intestine

26.5

21.3

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

21.1

300

1665

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

3.9

21.1

157

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

21.0

1013

7484

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

5.9

20.8

WB600

NOMESCO Finland

Neoadjuvant therapy of primary tumour with antibodies

+∞

20.8

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

20.8

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

20.8

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

20.8

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

20.8

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

+∞

20.8

8263/2-C18.9

ICD-O-3

Adenocarcinoma in situ in tubulovillous adenoma of colon, NOS

21.5

20.8

8263/2-C18.7

ICD-O-3

Adenocarcinoma in situ in tubulovillous adenoma of sigmoid colon

37.3

20.7

JJ7LT

NOMESCO Finland

Coagulation of focal hepatic lesion under CT guidance

210.5

20.6

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

210.5

20.6

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

110.3

20.6

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

20.5

1089

8173

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

22.4

20.3

UKC05

NOMESCO Finland

Cystoscopy and bladder biopsy

3.9

20.3

148

N06DX01

ATC

memantine; oral

0.6

20.1

357

5809

G04BE03

ATC

sildenafil; oral

4.4

20.1

115

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

6.4

20.1

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

3.6

20.0

177

LAF00

NOMESCO Finland

Unilateral salpingo-oophorectomy

3.8

19.8

155

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.9

19.8

336

WX610

NOMESCO Finland

Patient controlled analgesia

5.2

19.8

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

19.8

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

19.8

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

+∞

19.8

8000/3-C18.2

ICD-O-3

Neoplasm, malignant of ascending colon

+∞

19.8

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

+∞

19.8

8480/3-C18.6

ICD-O-3

Mucinous adenocarcinoma of descending colon

+∞

19.8

L01CA04

ATC

vinorelbine; systemic

+∞

19.8

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

19.8

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

19.8

K62.7

ICD-10 Finland

Radiation proctitis

+∞

19.8

C10AA07

ATC

rosuvastatin; oral

0.8

19.7

1569

19337

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.3

19.7

145

632

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

19.3

359

2153

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

31.3

19.2

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

3.0

19.2

288

KA1FN

NOMESCO Finland

Isotope renography

4.8

19.1

N05AX08

ATC

risperidone; systemic

0.6

19.1

291

4931

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

2.3

19.1

144

634

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

4.5

19.1

103

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.0

19.1

210

1071

JFH01

NOMESCO Finland

Laparoscopic colectomy with ileorectal anastomosis

55.1

18.9

R10.0

ICD-10 Finland

Acute abdomen

2.0

18.9

196

979

L01XX05

ATC

hydroxycarbamide; oral

14.8

18.9

WPA44, ,

SPAT

6.3

18.8

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

18.8

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

18.8

15302

ICD-8 Finland

Malignant neoplasm of large intestine, except rectum, Cacci

+∞

18.8

WF090

NOMESCO Finland

Profylactic radiotherapy

+∞

18.8

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

18.8

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

+∞

18.8

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

+∞

18.8

1CD02, ,

NOMESCO Finland

+∞

18.8

KCC10

NOMESCO Finland

Cystoprostatectomy

+∞

18.8

8000/3-C18.7

ICD-O-3

Neoplasm, malignant of sigmoid colon

+∞

18.8

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

18.8

XX7JT

NOMESCO Finland

Somatostatin isotope ablative therapy

+∞

18.8

QX9VV, ,

NOMESCO Finland

70.0

18.7

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

27.9

18.7

WW200, ,

SPAT

0.8

18.6

1323

16588

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

18.7

18.6

L04AX04

ATC

lenalidomide; oral

100.3

18.6

153

Kela drug reimbursment

Lenalidomid

100.3

18.6

Z08.1

ICD-10 Finland

Follow-up examination after radiotherapy for malignant neoplasm

190.4

18.5

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.7

18.3

1058

13678

KCH00

NOMESCO Finland

Suture of bladder

6.6

18.3

TJG20

NOMESCO Finland

Transanal irrigation

7.8

18.3

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.1

18.2

180

883

C10AX09

ATC

ezetimibe; oral

0.7

18.2

701

9691

JAH33

NOMESCO Finland

Opening of laparostomy

7.5

18.2

D47.3

ICD-10 Finland

Essential (haemorrhagic) thrombocythaemia

44.1

18.2

KCD32

NOMESCO Finland

Cystoscopic destruction of tumour of bladder

4.5

18.2

D01

ICPC

Abdominal pain/cramps general

1.5

18.1

650

4540

WX004

NOMESCO Finland

Patient-controlled sedation

4.2

18.1

116

D04.4

ICD-10 Finland

Carcinoma in situ: Skin of scalp and neck

4.2

18.0

112

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

18.0

839

6148

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

52.6

17.9

2390A

ICD-9 Finland

Neoplasm of unspecified nature, Digestive system

5.2

17.9

8240/3-C18.0

ICD-O-3

Neuroendocrine tumor, NOS, of cecum

+∞

17.7

384

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

+∞

17.7

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

17.7

L01AX03

ATC

temozolomide; systemic

+∞

17.7

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

17.7

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

17.7

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

17.7

9680/3-C18.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of cecum

+∞

17.7

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

17.6

2072

17357

JFF24

NOMESCO Finland

Laparoscopic transversostomy

36.8

17.6

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

95.3

17.6

JFK00

NOMESCO Finland

Division of adhesive band in intestinal obstruction

5.7

17.5

JJB40

NOMESCO Finland

Excision of segments II, III and IV of liver

180.4

17.5

TQW40

NOMESCO Finland

Remowal of suture of skin

1.7

17.4

353

2168

JFB21

NOMESCO Finland

Laparoscopic ileocaecal resection

13.1

17.4

JFG29

NOMESCO Finland

Closure of terminal enterostomy with anastomosis to rectum

20.9

17.3

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.5

17.2

105

421

8263/2-C20.9

ICD-O-3

Adenocarcinoma in situ in tubulovillous adenoma of rectum, NOS

12.5

17.1

JK4ZT

NOMESCO Finland

Percutaneous transhepatic implantation of bile duct prothesis

50.1

17.0

JAK00

NOMESCO Finland

Laparotomy and drainage of peritoneal cavity

7.5

16.9

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

16.7

8070/3-C44.6

ICD-O-3

Squamous cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

16.7

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

16.7

8249/3-C18.0

ICD-O-3

Neuroendocrine tumor, grade 2 of cecum

+∞

16.7

1523, ,

Kela drug reimbursment

+∞

16.7

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

+∞

16.7

C17.0

ICD-10 Finland

Malignant neoplasm: Duodenum

+∞

16.7

3054, ,

Kela drug reimbursment

+∞

16.7

WZA10

NOMESCO Finland

Extensive medical or dental certificate

3.0

16.6

241

XQ902

NOMESCO Finland

Other photography

2.9

16.6

268

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.0

16.5

171

854

Z2446

NOMESCO Finland

Social worker

1.7

16.5

304

1819

XJH00

NOMESCO Finland

Transanal ultrasonography

1.6

16.5

365

2290

KEB00

NOMESCO Finland

Biopsy of prostate

3.7

16.5

138

U76

ICPC

Malignant neoplasm of bladder

170.3

16.5

JJB53

NOMESCO Finland

Excision of segments IV,V, VI, VII and VIII of liver

170.3

16.5

JAA10

NOMESCO Finland

Excision of lesion of abdominal wall

27.6

16.5

WVA20

NOMESCO Finland

Medicine administration

2.1

16.4

159

775

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

40.1

16.3

WPA11

NOMESCO Finland

Developing a plan for palliative care

6.8

16.1

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

30.1

16.1

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

2.9

16.0

263

JFG26

NOMESCO Finland

Closure of terminal enterostomy with anastomosis to colon

24.5

16.0

K59.09

ICD-10 Finland

Constipation, unspecified

1.5

15.9

476

3203

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.3

15.9

119

524

D04.7

ICD-10 Finland

Carcinoma in situ: Skin of lower limb, including hip

4.4

15.9

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

15.7

1725

14294

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

15.6

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

+∞

15.6

8720/3-C44.6

ICD-O-3

Malignant melanoma, NOS, of skin of upper limb and shoulder

+∞

15.6

C56.98

ICD-10 Finland

Malignant tumor of the ovary, indeterminate histology

+∞

15.6

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

15.6

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

+∞

15.6

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

15.6

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

15.6

JF2BD

NOMESCO Finland

Extensive colon CT

2.8

15.6

272

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.8

15.6

1423

17341

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

2.7

15.5

295

XX3AT

NOMESCO Finland

Other labeling with ultrasound guidance

19.2

15.5

8263/2-C18.0

ICD-O-3

Adenocarcinoma in situ in tubulovillous adenoma of cecum

22.1

15.5

FM1FN

NOMESCO Finland

Heart function isotope examination

160.3

15.5

JJA40

NOMESCO Finland

Excision of lesion of liver

160.3

15.5

C44.91

ICD-10 Finland

Unspecified localization of basocellular carcinoma of the skin

13.7

15.5

C182, 8148, 2

ICD-O-3

38.1

15.4

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

11.2

15.2

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.2

15.1

131

612

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

4.7

15.1

GDC00

NOMESCO Finland

Lobectomy of lung

13.0

15.1

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.2

15.1

130

607

D06BX01

ATC

metronidazole; topical

1.5

15.0

539

3765

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

10.8

14.9

SPAT1262

SPAT

Handing over of treatment supplies

1.3

14.9

1139

9000

K63.0

ICD-10 Finland

Abscess of intestine

6.8

14.8

A41.9

ICD-10 Finland

Sepsis, unspecified

1.8

14.8

237

1365

C184, 8148, 2

ICD-O-3

56.8

14.8

JA3CT

NOMESCO Finland

Cathetrisation of abdominal cavity with CT guidance

16.5

14.7

B02AA02

ATC

tranexamic acid; systemic

1.4

14.7

595

4250

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

18.4

14.7

A28

ICPC

Limited function/disability NOS

1.3

14.7

1435

11712

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.3

14.6

1467

12008

8490/3-C18.0

ICD-O-3

Signet ring cell carcinoma of cecum

+∞

14.6

C66

ICD-10 Finland

Malignant neoplasm of ureter

+∞

14.6

8480/3-C18.8

ICD-O-3

Mucinous adenocarcinoma of overlapping lesion of colon

+∞

14.6

C32.0

ICD-10 Finland

Malignant neoplasm: Glottis

+∞

14.6

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

14.6

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

14.6

329

Kela drug reimbursment

Lenalidomide

80.3

14.6

JFA98, ,

SPAT

80.3

14.6

C54.1

ICD-10 Finland

Malignant neoplasm: Endometrium

150.3

14.5

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

150.3

14.5

Z29.9

ICD-10 Finland

Prophylactic measure, unspecified

3.2

14.4

176

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.4

14.3

152

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

27.2

14.2

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.3

14.2

886

6800

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

14.4

14.0

D04.6

ICD-10 Finland

Carcinoma in situ: Skin of upper limb, including shoulder

3.9

13.9

103

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

2.8

13.9

239

TKE10

NOMESCO Finland

Puncture of prostate

23.8

13.8

UKB02

NOMESCO Finland

Retrograde ureteroscopy

2.9

13.8

213

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

13.7

335

2154

JK3NB

NOMESCO Finland

Percutaneous transhepatic cholangiography

6.2

13.7

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.5

13.7

333

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.8

13.6

1269

15474

R31

ICD-10 Finland

Unspecified haematuria

1.4

13.6

648

4759

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

5.1

13.6

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.2

13.6

117

547

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

4.3

13.5

C78.5

ICD-10 Finland

Secondary malignant neoplasm of large intestine and rectum

+∞

13.5

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

13.5

1XA03, ,

NOMESCO Finland

+∞

13.5

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

+∞

13.5

8743/3-C44.9

ICD-O-3

Low cumulative sun damage melanoma of skin, NOS

+∞

13.5

8500/3-C50.3

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast

+∞

13.5

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

13.5

WE100

NOMESCO Finland

Profylactic cytostatic therapy

+∞

13.5

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

+∞

13.5

N06DA02

ATC

donepezil; oral

0.6

13.5

288

4498

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

3.9

13.5

101

C26.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of digestive system

140.2

13.4

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

140.2

13.4

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

140.2

13.4

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.6

13.4

310

4755

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

1.8

13.4

194

1085

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

2.4

13.4

372

D07AA02

ATC

hydrocortisone; topical

1.4

13.4

707

5284

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

25.8

13.3

A21

ICPC

Risk factor for malignancy

25.8

13.3

ZYC01

NOMESCO Finland

Remote contact by phone

1.6

13.3

300

1894

RD211, ,

NOMESCO Finland

1.7

13.3

228

1341

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.4

13.2

350

ZXA00

NOMESCO Finland

Right side

1.2

13.2

1633

13677

JAL01

NOMESCO Finland

Laparoscopic biopsy of peritoneum

13.8

13.2

JLC10

NOMESCO Finland

Distal pancreatectomy

13.8

13.2

TQB05

NOMESCO Finland

Puncture of skin of trunk

5.7

13.2

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.8

13.2

1065

13222

KFC10

NOMESCO Finland

Bilateral orchiectomy

40.1

13.1

K91.3

ICD-10 Finland

Postoperative intestinal obstruction

15.0

13.1

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

2.9

13.1

214

WPA43, ,

SPAT

10.9

13.0

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

3.4

13.0

137

C44.3

ICD-10 Finland

Malignant neoplasm: Skin of other and unspecified parts of face

28.4

12.9

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

28.4

12.9

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

5.2

12.9

KH1CD

NOMESCO Finland

Very extensive urinary tract ultrasound examination

3.0

12.9

183

JJA21

NOMESCO Finland

Laparoscopic biopsy of liver

6.1

12.9

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

2.8

12.9

232

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

0.8

12.8

1517

18016

JFA68

NOMESCO Finland

Endoscopic insertion of prosthetic tube into colon

50.1

12.8

LAE20

NOMESCO Finland

Bilateral oophorectomy

4.4

12.8

D18

ICPC

Change in faeces/bowel movements

1.9

12.8

154

814

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

310

261

12.35

309.11

4.4

1.6

6.30

5.18

nmol/l

0.19

304

249

(40768804) Tissue Pathology biopsy report

3716

17961

3.16

307.65

2.7

1.7

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

4968

31696

2.76

307.65

16.3

6.2

4.10

4.43

e9/l

14.63

4347

26757

(3044640) Blood type and Crossmatch panel - Blood

3914

18063

3.50

307.65

3.2

2.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

5486

3372

61.46

307.65

9.4

1.4

36.73

11.22

ug/l

2.12

5075

2545

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2448

9833

3.23

307.65

2.4

2.7

17.78

21.66

35.13

2364

8989

(4035726) Immunohistochemistry procedure

1815

1506

15.68

307.65

1.4

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

922

742

14.06

307.65

5.6

2.0

231.77

29.67

u/ml

4.85

842

668

(3002256) Pathology report gross observation

1428

4488

3.71

307.65

1.4

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3150

13698

3.28

307.65

3.0

2.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1792

1248

18.67

307.65

5.8

1.8

1726.39

137.49

u/ml

2.61

1624

1012

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3424

17841

2.72

307.65

2.5

3.79

2.83

mg/l

48.92

3054

15309

(3022948) Iron [Moles/volume] in Serum or Plasma

2672

11453

3.10

307.65

2.5

2.7

10.59

12.27

umol/l

21.84

2569

10470

(3022145) Colonoscopy Study observation

2879

6145

7.06

307.65

1.5

1.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1935

4912

4.99

307.65

2.5

2.0

0.20

g/l

0.87

1867

4457

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5355

30644

3.76

307.65

14.6

3.9

11.85

12.24

umol/l

1.29

5244

28771

(3033658) Prothrombin time (PT) actual/Normal

2981

14469

2.78

307.65

5.4

3.8

86.50

84.51

4.00

2946

14149

(3024561) Albumin [Mass/volume] in Serum or Plasma

5104

28108

3.68

307.65

9.5

4.0

33.65

35.29

g/l

71.64

4949

25836

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4898

26029

3.65

307.65

3.6

2.5

—

estimate

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2566

10673

3.16

307.65

2.4

2.7

2.42

2.28

g/l

27.64

2474

9708

(3023368) Bacteria identified in Blood by Culture

3357

18599

2.48

305.74

5.0

4.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

364

463

8.22

268.42

2.1

1.8

271.15

12.39

u/ml

0.80

358

454

(3032080) INR in Blood by Coagulation assay

4717

31658

2.37

262.68

17.2

19.7

1.28

1.37

inr

24.34

4094

26657

(3037121) Protein [Mass/volume] in Urine

770

2074

4.03

251.55

5.8

2.6

362.44

518.91

mg/l

0.43

587

757

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1522

6351

2.76

241.61

3.3

2.1

10.00

8.05

umol/l

2.02

1376

5500

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6018

45893

2.73

240.36

16.5

5.8

94.06

77.25

u/l

49.86

5870

42756

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3330

19890

2.23

237.33

3.2

2.4

56.93

61.49

u/l

1.90

3196

18248

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

168

22.90

230.87

2.2

1.1

21.24

15.30

u/ml

1.23

162

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1050

3729

3.12

222.58

8.6

9.9

15.47

16.03

9.31

1028

3604

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4057

26646

2.17

222.52

3.4

3.1

112.62

134.25

ug/l

7.07

3800

24441

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4693

32942

2.18

212.72

8.9

6.3

1.20

1.21

mmol/l

38.12

4102

28147

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1948

9846

2.33

201.36

4.9

2.4

0.80

0.82

mmol/l

13.89

1866

9027

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1473

6636

2.53

196.24

8.2

8.0

114.08

122.03

g/l

45.65

1446

6488

(3013826) Glucose [Moles/volume] in Serum or Plasma

5076

37511

2.14

190.65

6.6

4.9

6.90

6.89

mmol/l

0.21

4937

35630

(3015377) Calcium [Moles/volume] in Serum or Plasma

3292

20784

2.06

190.54

8.0

2.2

2.35

mmol/l

0.75

3097

18172

(3016502) Oxygen saturation in Arterial blood

1556

7347

2.42

186.14

7.9

7.5

96.47

94.94

17.72

1520

7084

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1146

4692

2.71

184.84

1.7

1.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4219

29427

2.02

181.49

8.0

5.9

1.20

1.21

mmol/l

20.72

3989

26643

(3019977) pH of Arterial blood

1659

8163

2.33

179.97

7.7

7.2

7.41

7.42

7.46

822

4747

(3027801) Oxygen [Partial pressure] in Arterial blood

1646

8178

2.31

173.84

7.7

7.2

13.84

11.42

kpa

54.53

1604

7836

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1646

8184

2.30

173.50

7.7

7.2

5.13

5.04

kpa

4.04

1607

7853

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1230

5373

2.55

173.05

2.8

2.2

39.31

39.14

u/l

0.02

1091

4473

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2296

13048

2.11

172.91

8.2

2.3

2.48

2.45

mmol/l

20.34

2177

11450

(3003694) ABO and Rh group [Type] in Blood

2441

14272

2.06

169.65

1.4

1.3

—

(3003396) Base excess in Arterial blood by calculation

1628

8126

2.29

169.58

7.7

7.2

0.37

1.15

mmol/l

12.63

1364

6614

(40768441) Liver Pathology biopsy report

187

190

10.07

163.76

1.1

1.4

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

106

29.86

160.41

2.7

1.0

42.81

17.48

u/ml

0.80

106

(3014111) Lactate [Moles/volume] in Serum or Plasma

1301

6033

2.41

159.73

7.2

7.1

1.24

1.42

mmol/l

7.10

1280

5901

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

539

1575

3.61

154.55

2.9

1.5

58.80

25.81

u/ml

4.27

529

1486

(3000991) Gas panel - Venous blood

1229

5736

2.37

147.76

8.1

8.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

645

2175

3.15

146.90

2.4

3.0

0.32

0.35

iu/ml

1.42

353

1258

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1315

6364

2.30

145.11

3.4

2.1

238.42

237.05

u/l

0.14

1253

5885

(42870588) Differential panel, method unspecified - Blood

2983

19714

1.86

137.43

5.2

5.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

925

3936

2.54

135.38

8.7

9.2

23.79

24.33

mmol/l

6.26

916

3818

(3006504) Eosinophils/Leukocytes in Blood

3784

27003

1.83

135.12

5.6

5.7

2.64

2.95

13.55

3556

24922

(3019069) Monocytes/Leukocytes in Blood

3788

27057

1.83

134.67

5.7

5.8

9.22

9.08

1.78

3551

24969

(3002030) Lymphocytes/Leukocytes in Blood

3830

27542

1.82

132.24

5.7

24.08

26.40

29.78

3627

25738

(3022096) Basophils/Leukocytes in Blood

3778

27076

1.81

131.74

5.7

5.8

0.61

0.66

8.15

3544

24991

(3027945) Reticulocytes/Erythrocytes in Blood

1518

8173

2.08

126.23

2.1

2.0

1.83

1.77

1.50

1357

7109

(3018010) Neutrophils/Leukocytes in Blood

3738

27041

1.78

123.10

5.6

60.09

58.39

13.42

3576

25544

(3006315) Basophils [#/volume] in Blood

4012

29825

1.76

118.30

5.3

5.5

0.04

e9/l

3.84

3330

25189

(3020779) Urea [Moles/volume] in Serum or Plasma

1207

6119

2.16

116.63

5.9

6.8

9.59

11.51

mmol/l

15.49

1158

5762

(3001604) Monocytes [#/volume] in Blood

3989

29676

1.75

116.63

5.3

5.5

0.64

0.62

e9/l

4.57

3306

25042

(3019198) Lymphocytes [#/volume] in Blood

4059

30369

1.75

116.09

5.5

1.74

1.81

e9/l

1.04

3463

26235

(3042936) Bacteria identified in Isolate by Culture

1556

8700

2.00

115.34

2.2

2.1

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2759

18614

1.77

112.55

4.7

2.7

39.44

35.63

u/l

0.46

2625

17319

(3013115) Eosinophils [#/volume] in Blood

4067

30676

1.73

110.78

5.5

5.6

0.18

0.20

e9/l

9.44

3441

26307

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

868

4013

2.32

104.28

7.7

8.1

24.41

24.83

mmol/l

2.99

862

3972

(4281824) Cell count and differential, peritoneal fluid

170

269

6.44

102.47

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

412

1326

3.23

100.68

1.9

2.3

3.67

3.63

g/l

0.19

402

1256

(3002582) Erythrocytes [#/volume] in Urine

2987

21083

1.70

100.45

3.8

3.4

55.57

85.91

e6/l

1.05

2330

16123

(3030467) Casts [#/volume] in Urine by Automated count

2637

18061

1.72

98.61

3.6

3.3

0.58

0.49

e6/l

0.69

1998

13298

(40768795) Lymph node Pathology biopsy report

11.93

97.84

1.2

1.1

—

(3023520) Reticulocytes [#/volume] in Blood

1174

6314

2.02

95.28

2.1

70.21

67.98

e9/l

1.15

872

4713

(3031040) Bacteria [#/volume] in Urine by Automated count

4995

40708

1.71

94.69

5.3

5.0

2144.96

2287.97

e6/l

0.05

681

(36304419) Bacteria [Presence] in Urine

2475

16895

1.70

92.20

3.6

3.2

0.00

151.78

estimate

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1426

8424

1.86

86.69

5.1

5.6

1.01

1.04

mmol/l

3.23

1340

7700

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

15.67

84.56

1.2

1.1

—

(40758558) Short blood count panel - Blood

2479

17295

1.65

82.88

11.6

4.7

—

(3018095) Leukocytes [#/volume] in Urine

3168

23510

1.61

82.32

4.5

3.9

126.17

131.62

e6/l

0.09

2374

16617

(40768800) Prostate Pathology biopsy report

167

322

5.28

81.88

1.2

1.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1613

10156

1.75

78.26

3.4

3.0

2.61

2.57

e6/l

0.05

841

4985

(3026782) Osmolality of Urine

1884

12383

1.70

78.25

3.3

3.0

541.26

529.44

mosm/kgh2o

1.52

1698

10736

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

371

1304

2.94

77.63

1.9

2.3

216.93

197.83

3.51

360

1226

(3018418) pH of Serum or Plasma

2689

19471

1.60

75.51

4.8

3.5

7.39

7.40

2.34

1902

13894

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

603

2760

2.29

73.13

2.0

1.8

1.51

2.07

ug/l

1.11

543

2383

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4387

35849

1.56

70.36

4.0

3.2

72.58

49.51

u/l

21.18

4150

32894

(40768793) Breast Pathology biopsy report

149

311

4.87

66.70

1.4

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

492

2168

2.36

64.98

1.4

1.2

—

(3026008) Bacteria identified in Urine by Culture

2782

20816

1.54

64.94

3.5

—

(40768797) Stomach Pathology biopsy report

1349

8496

1.72

63.79

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6363

57480

1.80

62.53

30.6

16.5

37.76

25.64

mg/l

117.09

6033

47608

(3037467) Urinalysis macro (dipstick) panel - Urine

4935

42098

1.53

59.27

5.8

4.8

1.77

2.30

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1671

11353

1.61

58.19

3.4

2.9

1.24

1.18

e6/l

0.24

899

6195

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1728

11849

1.60

57.85

2.0

1.9

—

(3000850) Epithelial cells [#/volume] in Urine

2051

14727

1.54

55.77

2.9

2.7

5.63

4.93

e6/l

1.73

1890

13325

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1503

10136

1.61

53.34

2.0

1.9

29.85

0.01

1471

9853

(1617658) Protocol used for examination of sentinel lymph nodes

+∞

53.18

1.1

0.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

228

758

3.07

52.54

1.3

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

620

3281

1.97

50.90

1.4

1.6

1.76

1.56

g/l

5.92

537

2798

(3007930) Methemoglobin/Hemoglobin.total in Blood

589

3073

2.00

50.35

5.9

4.9

0.87

0.86

0.11

562

2918

(3036489) Thrombin time

420

1942

2.23

49.30

1.9

1.8

21.13

21.15

0.02

397

1728

(3004809) Band form neutrophils/Leukocytes in Blood

214

720

3.03

48.31

2.6

2.3

2.36

1.19

3.19

195

612

(3039000) Anion gap in Blood by calculation

329

1404

2.41

46.52

7.5

6.8

11.12

11.45

mmol/l

1.08

305

1271

(3018572) Chloride [Moles/volume] in Blood

329

1404

2.41

46.52

7.5

6.8

106.00

104.63

mmol/l

6.04

305

1271

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

614

3366

1.90

45.21

5.7

4.7

1.55

1.58

0.46

588

3201

(3021589) Normoblasts [#/volume] in Blood

3192

25792

1.42

44.99

17.2

10.7

0.00

e9/l

0.78

2511

20953

(3012544) pH of Venous blood

1142

7511

1.62

44.04

3.4

3.7

7.38

0.11

702

4388

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

655

3707

1.84

43.59

2.6

2.5

—

(3002032) Base excess in Venous blood by calculation

1095

7234

1.60

41.22

3.4

3.6

1.67

1.84

mmol/l

0.74

914

6323

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1117

7442

1.59

40.52

3.4

3.6

5.67

5.83

kpa

6.42

1092

7250

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

7.39

40.20

2.0

2.4

778.22

4.63

ug/l

0.50

(3019225) pH of Specimen

988

6424

1.62

39.60

4.8

3.8

7.37

7.36

1.89

806

4250

(3008152) Bicarbonate [Moles/volume] in Arterial blood

770

4696

1.71

39.51

7.7

6.6

24.09

24.51

mmol/l

2.42

741

4516

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

301

1334

2.31

39.03

1.4

1.5

—

(3019060) Gas panel - Arterial blood

742

4521

1.71

38.14

5.8

4.6

—

(3047181) Lactate [Moles/volume] in Blood

411

2082

2.03

37.96

6.8

5.8

1.45

1.35

mmol/l

0.90

375

1860

(3017181) Myelocytes/Leukocytes in Blood

793

5011

1.65

35.39

3.5

3.6

0.96

0.72

1.94

311

1105

(3045142) Bone marrow Pathology biopsy report

101

262

3.89

34.31

1.3

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

6451

60308

1.57

34.13

37.4

20.9

139.25

139.76

mmol/l

48.68

6382

59017

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

772

4889

1.65

34.10

1.4

1.5

—

(3021440) Promyelocytes/Leukocytes in Blood

765

4855

1.64

33.48

3.5

3.7

0.13

0.06

1.36

284

958

(3002179) Metamyelocytes/Leukocytes in Blood

755

4777

1.65

33.44

3.3

3.5

0.89

0.55

2.63

290

1086

(3023103) Potassium [Moles/volume] in Serum or Plasma

6454

60405

1.57

33.26

37.5

21.1

3.97

4.00

mmol/l

16.86

6379

59024

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

342

1719

2.04

32.24

1.7

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

8.74

31.87

6.6

1.2

11.80

79.39

ug/l

3.11

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1258

9024

1.48

31.65

1.9

1.8

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

104

299

3.51

30.45

1.4

1.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

207

871

2.42

30.23

5.6

6.2

11.87

12.61

mg/l

1.62

187

790

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

30.22

1.1

0.0

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

644

4024

1.66

29.83

3.1

3.8

23.87

24.24

mmol/l

1.88

632

3959

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

5969

55284

1.43

29.49

32.2

16.1

74.89

73.61

ml/min/173m2

5.36

5690

51263

(3021960) Folate [Moles/volume] in Serum or Plasma

2570

21090

1.34

28.63

1.8

1.7

20.57

20.26

nmol/l

0.38

2228

17622

(3025159) Blasts/Leukocytes in Blood

752

4930

1.59

28.59

3.4

3.8

0.03

0.15

252

925

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

582

3581

1.68

28.57

1.6

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

768

5076

1.57

28.17

4.5

3.3

1.22

1.23

mmol/l

0.54

697

4210

(3025941) Bacteria identified in Stool by Culture

480

2857

1.73

26.60

1.2

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

443

2585

1.76

26.33

1.9

1.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

926

6471

1.49

26.14

4.6

3.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

327

1757

1.90

25.42

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

410

2380

1.77

24.80

1.9

1.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1143

8421

1.42

24.32

1.9

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6392

60402

1.45

24.21

20.9

11.1

25.08

25.00

u/l

0.12

6281

57995

(3049717) Cytology report of Urine Cyto stain

384

2203

1.78

24.18

2.8

1.8

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

178

780

2.31

23.79

1.4

1.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1513

11742

1.36

23.50

4.3

4.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

894

6330

1.47

23.48

3.1

4.43

4.42

kpa

0.05

871

6143

(3042111) Morphology [Interpretation] in Bone marrow Narrative

143

576

2.51

23.03

1.4

1.2

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

6475

61446

1.46

22.89

41.7

22.1

82.75

82.86

umol/l

0.08

6413

60504

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

172

759

2.30

22.63

1.4

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

167

728

2.32

22.61

1.4

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

166

723

2.33

22.52

1.4

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

167

731

2.31

22.40

1.4

1.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3598

31583

1.27

22.13

2.4

2.3

90.46

94.70

pmol/l

5.99

2158

16446

(3019309) Folate [Moles/volume] in Red Blood Cells

1740

13897

1.33

22.13

1.7

1.8

1188.23

1153.82

nmol/l

0.70

1331

10474

(3044889) 12 lead EKG panel

4716

42814

1.28

21.95

4.8

4.6

0.17

1125.79

—

108

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

133

4.23

21.54

3.4

2.2

1.61

1.04

0.84

133

(3024522) Salmonella sp identified in Specimen by Organism specific culture

170

764

2.25

21.44

1.4

1.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

993

7290

1.42

21.34

1.8

1.9

—

(3013727) Leukocytes other/Leukocytes in Blood

102

4.63

20.26

2.8

2.5

53.43

57.86

0.64

(3017354) Segmented neutrophils/Leukocytes in Blood

128

521

2.48

20.22

2.6

2.3

60.77

61.09

0.06

109

432

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

5009

46014

1.28

20.16

40.3

20.0

14.77

13.72

251.13

4983

45266

(3017143) Hepatitis C virus Ab [Presence] in Serum

636

4368

1.50

19.30

1.4

1.6

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

156

714

2.21

18.88

1.2

1.1

1.59

1.55

g/l

0.54

149

645

(3004119) Hemoglobin [Mass/volume] in Venous blood

672

4697

1.47

18.67

3.0

3.2

120.26

129.72

g/l

19.65

657

4563

(3023487) Leukocytes [#/volume] in Peritoneal fluid

173

3.55

18.38

1.6

2.5

10689.40

626.52

e6/l

0.51

122

(3052851) Hemolysis interference index of Serum or Plasma

306

1786

1.74

18.19

4.5

3.5

1.67

1.59

index

0.10

178

873

(3000012) Reticulocyte production index

192

966

2.01

18.16

2.0

1.7

0.82

0.91

1.45

145

626

(3007461) Platelets [#/volume] in Blood

6482

61939

1.40

18.14

48.3

24.8

252.89

240.72

e9/l

32.94

6369

60295

(3024731) MCV [Entitic mean volume] in Red Blood Cells

6482

61945

1.40

18.07

48.0

24.8

91.05

91.68

18.81

6427

61004

(3026361) Erythrocytes [#/volume] in Blood

6482

61949

1.40

18.03

48.2

24.8

4.27

4.45

e12/l

143.77

6341

60016

(3018405) Lactate [Moles/volume] in Arterial blood

390

2436

1.63

17.97

4.5

3.9

1.37

1.42

mmol/l

0.30

384

2374

(3035941) MCH [Entitic mass]

6481

61944

1.39

17.96

48.0

24.7

29.96

30.47

71.49

6425

61004

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

6481

61946

1.39

17.94

49.3

25.3

38.11

40.18

92.83

6420

60990

(3000963) Hemoglobin [Mass/volume] in Blood

6482

61959

1.39

17.92

48.6

25.0

125.99

134.72

g/l

307.65

6428

61040

(3010813) Leukocytes [#/volume] in Blood

6481

61959

1.39

17.80

48.2

24.8

7.08

6.81

e9/l

14.91

6351

60015

(3008757) Leukocyte morphology finding [Identifier] in Blood

113

462

2.47

17.73

2.6

2.5

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

17.71

1.1

0.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2159

25306

0.79

17.58

1.9

2.0

1.39

1.31

mmol/l

4.32

1774

20775

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2767

24008

1.24

17.22

3.1

3.4

1638.44

1690.02

ng/l

0.21

2439

20957

(40761536) Microorganisms panel - Urine sediment

638

4490

1.46

17.08

4.5

4.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1620

13210

1.29

16.98

1.8

1.7

1.88

1.31

mg/l

6.87

1342

10335

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1695

13912

1.28

16.87

4.0

4.4

382.28

504.06

ng/l

0.36

1458

11911

(3009261) Glucose [Presence] in Urine by Test strip

3737

33593

1.23

16.37

4.7

4.2

1.15

0.02

estimate

0.49

873

6287

(3023183) Ammonium ion [Moles/volume] in Plasma

240

1347

1.81

16.33

2.2

2.4

30.02

33.16

umol/l

1.56

221

1195

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

146

3.58

15.95

1.7

2.3

14707.06

26029.19

e6/l

0.28

(3043410) Blood group antigens tested for on Red Blood Cells

156

3.48

15.87

2.3

1.9

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3063

27027

1.23

15.87

4.4

42.78

93.28

ng/l

3.43

2527

20722

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

4874

45169

1.23

15.46

4.2

4.6

17.69

13.15

mm/h

52.11

4455

41836

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

330

2.62

15.44

2.3

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

162

821

1.99

15.08

3.9

5.0

390.78

994.85

iu/ml

0.99

116

(3021601) Nitrite [Presence] in Urine by Test strip

3641

32934

1.21

14.02

4.7

4.2

0.00

estimate

0.86

880

6565

(3044007) Cell count panel - Peritoneal fluid

142

3.40

13.65

1.8

2.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

154

801

1.94

13.36

2.4

2.0

1.27

1.30

g/24h

0.03

100

441

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

100

444

2.27

13.15

1.3

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

161

855

1.90

13.13

1.4

1.5

31.08

28.21

g/l

2.15

145

738

(3035350) Ketones [Presence] in Urine by Test strip

3678

33450

1.20

12.90

4.7

4.2

4.74

3.58

estimate

0.16

909

6804

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

5.49

12.09

1.4

2.2

60.71

64.04

0.14

(3000570) Elastase.pancreatic [Mass/mass] in Stool

290

1859

1.58

12.08

1.4

231.10

278.08

ug/g

3.48

182

1128

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

437

2.21

11.94

1.4

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

394

2708

1.48

11.90

1.9

2.2

351.81

699.19

ug/l

2.99

383

2584

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

290

2.50

11.81

1.3

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

290

2.50

11.81

1.3

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

144

766

1.90

11.73

1.4

1.5

1140.34

2657.86

e6/l

1.98

111

538

(3012441) Differential panel - Pleural fluid

125

634

1.99

11.71

1.4

1.5

—

(3017732) Neutrophils [#/volume] in Blood

915

7239

1.30

11.69

4.4

2.8

4.52

4.73

e9/l

0.36

759

6037

(3036782) Glucose [Moles/volume] in Pleural fluid

114

569

2.02

11.19

1.3

1.4

6.23

6.56

mmol/l

0.56

107

521

(3035933) Granulocytes/Leukocytes in Blood

175

1005

1.76

11.15

3.3

3.1

58.35

59.02

0.28

175

1005

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

652

4949

1.35

11.14

3.7

2.5

62.88

60.58

ml/min/173m2

0.89

316

2041

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

141

3.13

11.07

1.1

1.3

901.03

3.79

ug/l

0.85

(3027273) Bicarbonate [Moles/volume] in Venous blood

492

3576

1.40

11.00

3.6

3.3

24.68

25.21

mmol/l

2.46

482

3456

(3041096) Erythrocytes [Presence] in Urine by Automated

1908

16512

1.21

10.94

4.5

3.7

0.45

0.34

estimate

0.11

714

5062

(40768806) Pleura Pathology biopsy report

114

574

2.00

10.93

1.4

1.5

—

(3012501) Base excess in Blood by calculation

218

1337

1.65

10.92

4.2

2.65

2.63

mmol/l

0.03

157

893

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

112

561

2.01

10.90

1.3

302.64

323.23

u/l

0.18

106

520

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

621

4696

1.35

10.87

4.0

3.6

5.02

5.17

kpa

4.39

590

4450

(3013290) Carbon dioxide [Partial pressure] in Blood

218

1339

1.65

10.86

4.2

4.98

5.02

kpa

0.34

212

1300

(3028308) Erythrocytes [#/volume] in Pleural fluid

128

673

1.92

10.84

1.4

1.5

148108.84

62745.84

e6/l

0.69

367

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

226

1402

1.63

10.82

1.3

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

388

2711

1.45

10.79

1.2

1.4

—

(3024928) Oxygen saturation in Venous blood

274

1782

1.56

10.76

2.0

3.0

58.37

61.08

1.14

265

1701

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

797

10022

0.77

10.66

1.3

17.51

14.04

u/ml

0.45

283

3641

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

317

2136

1.51

10.58

2.5

2.9

—

(21494434) Karyotype in Bone marrow

300

2.38

10.55

1.1

—

(3027315) Oxygen [Partial pressure] in Blood

218

1350

1.63

10.52

4.2

8.92

8.38

kpa

2.52

212

1310

(3009343) pH of Capillary blood

602

4559

1.35

10.44

4.0

3.6

7.42

0.37

504

3785

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

857

10643

0.78

10.36

1.3

38.46

36.60

iu/ml

0.15

277

3240

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

164

946

1.75

10.32

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

228

1436

1.61

10.29

1.3

—

(3035715) Granulocytes [#/volume] in Blood

153

867

1.78

10.24

3.2

3.1

4.18

4.32

e9/l

0.34

153

867

(3000494) Fungus identified in Specimen by Culture

891

7151

1.28

10.13

1.4

—

(1616796) Gas panel - Central venous blood

232

1474

1.59

10.10

3.5

3.9

—

(1761482) Bacteria [#/volume] in Urine by Culture

275

1819

1.53

10.03

5.0

4.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

234

1493

1.59

10.01

1.2

95.00

160.72

titre

0.64

139

(3014765) Yersinia sp identified in Stool by Organism specific culture

245

1583

1.57

9.93

1.1

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

224

2.56

9.90

1.5

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

224

2.56

9.90

1.5

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

224

2.56

9.90

1.5

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

224

2.56

9.90

1.5

1.2

—

(3045788) Cell count panel - Pleural fluid

117

617

1.91

9.86

1.4

1.5

—

(3015736) pH of Urine

2941

26627

1.17

9.82

4.0

3.7

6.22

6.27

1.44

1603

14302

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

531

3983

1.36

9.80

3.8

3.5

1.80

2.00

mmol/l

0.50

378

2892

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

174

2.77

9.77

6.0

1.1

34.25

147.73

u/ml

1.41

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

242

1566

1.56

9.75

1.1

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

244

1590

1.55

9.54

1.1

1.2

—

(3019230) Fractional oxyhemoglobin in Venous blood

227

1455

1.58

9.54

1.9

2.5

58.15

61.95

1.60

227

1450

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

155

2.85

9.45

1.5

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

155

2.85

9.45

1.5

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

156

2.83

9.34

1.5

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

1909

16780

1.19

8.90

3.5

3.2

0.16

0.07

0.69

561

(3044242) Glucose [Moles/volume] in Arterial blood

416

2.06

8.90

2.1

1.7

7.60

8.34

mmol/l

1.66

416

(3030981) Hyaline casts [#/volume] in Urine by Automated count

714

5679

1.28

8.69

2.9

2.4

0.51

0.48

e6/l

0.17

694

5453

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

4.87

8.35

1.5

2.1

21.13

12.80

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

+∞

8.33

1.0

0.0

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

421

2.01

8.27

1.3

12.63

11.28

u/l

0.22

376

(3028626) Oxygen [Partial pressure] in Capillary blood

252

1712

1.49

8.16

3.4

2.9

8.06

7.85

kpa

0.69

244

1667

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

240

2.34

8.15

1.3

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

240

2.34

8.15

1.3

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

486

1.92

8.13

1.4

1.3

—

(21494814) CD8 cells/Lymphocytes in Specimen

108

3.06

8.10

2.1

33.94

25.02

2.22

108

(3005532) Lymphocytes/Leukocytes in Pleural fluid

188

2.51

7.95

1.3

1.4

58.21

62.31

0.30

152

(3020630) Protein [Mass/volume] in Serum or Plasma

723

5831

1.27

7.85

3.0

1.6

65.19

66.34

g/l

3.33

656

5187

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

524

1.86

7.69

1.4

1.3

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

162

2.60

7.66

1.4

1.5

3.60

2.92

0.13

137

(3023383) Lactate [Moles/volume] in Pleural fluid

168

2.57

7.64

1.3

4.05

3.01

mmol/l

0.66

150

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

101

558

1.82

7.47

3.0

2.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1197

10234

1.20

7.46

1.6

1.3

2.64

2.67

g/l

0.20

675

5693

(3026692) Albumin [Mass/volume] in Peritoneal fluid

147

2.66

7.45

1.0

1.7

15.72

13.92

g/l

0.69

105

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

102

566

1.81

7.44

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

111

632

1.77

7.43

4.9

3.7

12.90

12.87

index

0.00

296

(3000330) Specific gravity of Urine by Test strip

477

3679

1.32

7.33

4.9

3.6

1.02

ratio

0.95

428

3334

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3138

29050

1.14

6.87

2.4

—

(3021901) Oxygen saturation in Capillary blood

220

1510

1.47

6.84

2.6

2.9

89.42

89.06

0.33

214

1463

(3045424) Erythrocytes [Presence] in Urine

412

3148

1.33

6.78

3.4

2.0

0.11

0.29

estimate

0.28

923

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1419

12411

1.18

6.77

1.2

1.3

2.37

1.77

u/ml

0.65

349

3175

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

178

1174

1.53

6.71

1.4

1.5

—

(3035880) pH of Pleural fluid

323

2.02

6.64

1.3

7.44

7.43

0.13

214

(4034850) Laboratory test

137

2142

0.63

6.59

14.5

11.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

207

1419

1.47

6.49

1.3

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

207

1419

1.47

6.49

1.3

1.4

—

(3022313) Gas panel - Capillary blood

414

3188

1.32

6.47

4.5

3.7

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

627

5091

1.25

6.44

2.8

1.8

415.67

375.65

nmol/l

3.59

593

4592

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1712

15262

1.16

6.36

1.8

12438939.91

29675198.58

pmol/l

1.04

1423

12391

(3015235) Bicarbonate [Moles/volume] in Capillary blood

340

2552

1.35

6.34

2.7

2.9

24.20

24.82

mmol/l

1.92

335

2506

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

2.89

6.29

1.5

1.1

2.88

2.93

ug/l

0.02

(3048689) Calprotectin [Mass/mass] in Stool

801

6713

1.22

6.11

1.9

2.2

252.67

152.15

ug/g

7.37

638

5253

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

185

2655

0.69

5.87

1.6

1.8

3.35

3.42

mmol/l

0.36

141

1920

(40765096) Chromosome analysis panel by Banding

3.52

5.87

1.1

—

(21494815) CD4 cells/Lymphocytes in Specimen

244

2.10

5.81

1.9

2.1

33.64

42.47

2.94

234

(3005719) IgG [Mass/volume] in Serum or Plasma

475

3793

1.27

5.65

3.0

2.3

10.67

10.79

g/l

0.19

438

3480

(3004716) Salmonella sp identified in Stool by Organism specific culture

285

2127

1.35

5.56

1.2

1.3

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3050

28447

1.12

5.50

2.4

76.33

79.26

nmol/l

6.86

2738

25005

(40758292) HTLV I+II Ab panel - Serum

3.62

5.47

1.8

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

3.62

5.47

1.1

1.0

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

321

2445

1.33

5.47

4.7

3.9

24.72

24.93

mmol/l

0.53

288

2205

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

198

2.18

5.41

2.2

2.0

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

198

2.18

5.41

2.1

1.9

17.93

17.26

0.12

190

(3000919) Neutrophils/Leukocytes in Pleural fluid

148

2.37

5.37

1.4

28.47

23.00

0.44

134

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

437

1.77

5.33

1.4

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

437

1.77

5.33

1.4

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

437

1.77

5.33

1.4

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

149

2.36

5.29

2.3

2.0

2993.80

72639.08

u/ml

—

(3017569) Oxygen content in Arterial blood

453

1.75

5.29

2.2

1.9

15.08

16.10

2.01

453

(3026051) Granulocytes/Leukocytes in Pleural fluid

126

2.47

5.18

1.3

1.4

25.00

28.60

0.26

101

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

249

2.01

5.16

1.9

1.7

—

(3037756) Immunofixation for Serum or Plasma

193

1372

1.42

5.08

1.7

1.2

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

10.01

5.02

2.6

1.8

215.22

184.33

ng/l

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

111

2.53

4.94

1.1

1.5

30.36

78.83

g/l

0.44

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

111

712

1.57

4.86

1.3

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

378

3000

1.27

4.77

2.2

1.5

1.62

1.19

g/l

1.13

348

2727

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

765

6552

1.19

4.63

3.2

3.3

218.45

238.97

ng/l

0.74

701

6037

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

419

1.73

4.63

1.6

1.8

1010.86

3372.63

u/l

0.93

173

(46235355) HIV 1 and 2 tests - Meaningful Use set

677

5738

1.20

4.61

1.5

1.6

—

(3036603) Volume of Urine

410

1.71

4.42

1.6

1.4

1787.66

1901.36

0.51

391

(1761868) Lipid panel - Serum or Plasma

1721

18817

0.89

4.39

3.3

3.6

—

(3029937) Albumin [Presence] in Urine by Test strip

2066

19036

1.12

4.37

4.9

4.4

0.00

estimate

0.08

773

5971

(3006184) Hemoglobin [Mass/volume] in Capillary blood

231

1741

1.34

4.31

1.9

2.2

118.75

130.29

g/l

8.35

182

1354

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

2.70

4.24

1.3

1.4

7.00

8.80

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2611

24395

1.11

4.24

5.7

4.4

3.35

2.16

ug/l

2.73

2320

21959

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

294

3717

0.78

4.12

1.9

2.1

3.39

3.43

ratio

0.21

250

3005

(3015171) Extractable nuclear Ab [Units/volume] in Serum

161

2211

0.72

4.07

1.2

0.46

0.77

u/ml

0.58

190

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

616

1.55

4.04

1.1

1.2

75.49

55.54

u/l

1.15

526

(3003181) Sodium [Moles/volume] in Urine

190

1407

1.36

4.01

1.4

53.17

61.16

mmol/l

2.31

133

1136

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

492

1.61

3.99

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

190

1411

1.36

3.94

1.5

1.6

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

4.45

3.93

6.2

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

120

2.25

3.79

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

554

1.56

3.79

1.8

2.3

2.19

1.60

u/field

0.49

292

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

130

915

1.43

3.73

1.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

364

2971

1.24

3.68

2.8

1.4

3.86

3.76

g/l

0.56

329

2643

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

365

2983

1.24

3.65

2.8

1.4

7.59

7.53

g/l

0.25

329

2652

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

162

2.04

3.64

1.9

2.2

0.62

mmol/l

0.02

162

(21494890) Protein electrophoresis panel - 24 hour Urine

616

1.52

3.63

2.2

1.3

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

364

2978

1.23

3.61

2.8

1.4

4.24

4.21

g/l

0.36

329

2652

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

115

801

1.44

3.51

1.3

1.4

—

(3022475) Manganese [Moles/volume] in Blood

5.30

3.50

1.8

1.0

0.18

0.14

umol/l

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

482

1.56

3.38

1.3

1.4

—

(3042631) Mycobacterium sp identified in Specimen

113

793

1.43

3.33

2.3

3.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

355

1.64

3.21

1.5

3.67

8.05

u/l

3.08

282

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

171

1294

1.33

3.20

1.3

—

(3037522) Nuclear Ab [Titer] in Serum

702

7964

0.87

3.14

1.3

506.41

518.23

titre

0.06

156

1850

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

339

2798

1.22

3.13

2.8

1.4

3.08

2.91

g/l

2.03

303

2468

(3045414) Leukocytes [Presence] in Urine

743

6554

1.15

3.13

3.1

2.0

0.02

0.01

estimate

0.39

133

1225

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

2.41

3.13

1.5

1.2

31.21

496.94

u/l

0.49

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

318

2609

1.23

3.11

2.6

1.4

10.05

10.13

g/l

0.11

279

2253

(3005322) IgE [Units/volume] in Serum or Plasma

274

3365

0.81

3.06

1.3

329.46

242.07

u/ml

0.39

252

3114

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

113

1557

0.72

3.01

1.4

1.6

4.22

4.84

mg/l

0.31

1167

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

583

0.55

3.01

1.0

52.42

44.31

ng/l

0.24

377

(3022493) Free Hemoglobin [Mass/volume] in Plasma

285

1.69

3.00

1.6

4.5

64.13

80.70

mg/l

0.63

188

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2619

24783

1.09

2.99

4.8

4.3

0.50

0.41

estimate

0.09

743

5278

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

580

0.55

2.96

1.0

678.52

697.35

ng/l

0.09

370

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2109

22437

0.92

2.95

2.1

2.3

252.09

240.36

u/l

0.19

1999

21039

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

578

0.55

2.93

1.0

364.50

333.60

ng/l

0.14

382

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

269

2184

1.24

2.93

3.1

1.5

3.61

1.62

ratio

1.16

167

1251

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1211

0.69

2.92

1.2

44.66

49.02

u/ml

—

127

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

105

747

1.41

2.92

1.3

1.4

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

381

1.58

2.90

1.3

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

168

1290

1.31

2.88

1.2

—

(3006270) Folate [Moles/volume] in Blood

616

1.45

2.88

1.3

1.2

320.17

338.02

nmol/l

0.32

475

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.09

2.88

1.3

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

148

1117

1.33

2.86

1.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

6.67

2.86

1.2

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

462

1.52

2.86

2.6

2.7

42.69

32.37

mg/l

0.99

346

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

609

5340

1.15

2.81

1.5

1.7

1.53

1.55

0.34

516

4523

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

103

739

1.40

2.75

1.3

1.2

0.18

0.20

nmol/l

1.10

608

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5597

57129

0.91

2.73

4.9

5.6

4.42

4.46

mmol/l

1.59

5093

52782

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5552

56688

0.91

2.73

4.9

5.5

1.43

1.45

mmol/l

3.80

5003

51979

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

5.00

2.72

2.0

1.1

25.63

26.53

umol/24h

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.50

2.69

1.2

—

(36660697) Celiac disease serology panel - Serum

507

4401

1.16

2.69

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

612

5391

1.15

2.66

3.8

99.40

97.06

ng/l

0.24

541

4514

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5533

56477

0.92

2.63

7.3

7.4

40.71

40.45

mmol/mol

1.29

5068

52218

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

344

1.57

2.61

1.1

1.2

203.02

84.52

u/l

0.85

284

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

377

1.54

2.57

1.4

1.5

13.70

14.18

umol/l

0.13

348

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

338

1.57

2.55

1.1

1.2

47.50

21.35

u/l

1.22

272

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

339

1.57

2.52

1.4

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

2.50

2.52

1.1

1.2

14.30

10.34

mg/l

0.34

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

129

977

1.33

2.49

1.2

31.13

20.51

u/l

1.37

112

828

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.46

2.48

1.2

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1800

16887

1.09

2.45

3.0

2.6

369.98

359.19

umol/l

3.61

1583

14428

(3003327) Ova and parasites identified in Stool by Light microscopy

217

1760

1.24

2.44

1.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

240

1969

1.23

2.43

3.4

0.85

0.83

nmol/l

0.26

201

1618

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

303

1.59

2.43

1.3

30.28

34.47

u/l

0.37

217

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1031

0.70

2.34

1.2

1.57

1.52

g/l

0.73

1031

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.82

2.34

1.2

1.1

—

(40768443) Skin Pathology biopsy report

299

2519

1.19

2.32

1.3

1.2

—

(44813793) Dust mix specific IgE antibody measurement

357

0.50

2.30

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

216

0.42

2.30

1.0

1.8

26.67

182.56

ug/l

—

199

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

256

2128

1.21

2.29

2.9

1.5

0.12

0.01

g/l

0.47

229

1912

(44806118) Parainfluenza type 4 nucleic acid detection

690

1.37

2.26

1.3

—

(44790047) Parainfluenza type 1 nucleic acid detection

690

1.37

2.26

1.3

—

(44790048) Parainfluenza type 2 nucleic acid detection

690

1.37

2.26

1.3

—

(44790049) Parainfluenza type 3 nucleic acid detection

690

1.37

2.26

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

444

0.56

2.24

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

443

0.56

2.22

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

300

2539

1.19

2.22

2.9

1.5

1.08

0.36

g/l

2.16

255

2157

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

293

3454

0.84

2.22

1.3

55.50

55.25

au/ml

0.01

230

(3004347) Hepatitis D virus Ab [Presence] in Serum

5.56

2.21

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

327

1.53

2.20

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

292

2468

1.19

2.20

3.1

1.5

44.84

34.88

mg/l

1.46

254

2058

(3009214) Lutropin [Units/volume] in Serum or Plasma

113

858

1.32

2.18

1.3

1.4

15.93

9.51

u/l

2.93

671

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

111

842

1.32

2.16

1.4

1.3

0.61

4.61

nmol/l

0.93

105

810

(3034860) Kappa light chains.free [Mass/volume] in Serum

292

2474

1.19

2.15

3.2

1.5

79.39

47.55

mg/l

0.91

254

2070

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

3.69

2.15

1.1

193.14

247.84

nmol/l

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

199

1625

1.23

2.15

3.1

2.7

1.89

1.81

mg/l

0.49

176

1398

(4094501) Cardiovascular stress test using bicycle ergometer

142

1794

0.79

2.14

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

522

0.61

2.09

1.1

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.20

2.09

1.0

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

139

1094

1.28

2.07

1.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

433

0.58

2.07

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

420

0.57

2.06

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

382

1.47

2.05

1.4

1.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.08

2.01

3.1

1.8

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

155

1.74

1.99

2.5

33.73

44.06

1.72

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

100

758

1.32

1.99

1.1

1.0

—

(40757494) Bilirubin.total [Moles/volume] in Blood

337

1.49

1.95

2.3

1.9

21.22

15.92

umol/l

—

(3018333) Ribosomal P Ab [Presence] in Serum

411

0.58

1.93

1.2

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

234

1.58

1.92

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

314

1.50

1.92

1.7

2.0

2.20

2.28

u/field

0.03

204

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

446

1.42

1.92

1.1

1.2

98.11

101.83

pmol/l

0.22

446

(3006462) Nitrate [Presence] in Urine

298

1.51

1.91

4.0

3.3

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

472

0.61

1.91

1.1

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1484

13948

1.08

1.91

3.3

3.1

0.88

0.74

ug/l

3.75

1059

9668

(3009466) Valproate [Moles/volume] in Serum or Plasma

899

0.72

1.90

4.3

4.5

346.50

343.48

umol/l

0.06

760

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

721

1.32

1.89

1.3

—

nmol/l

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

243

1.57

1.89

3.7

2.7

4.71

5.12

kpa

1.53

243

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

243

1.57

1.89

3.7

2.7

10.04

10.06

kpa

0.02

243

(3023420) DNA double strand Ab [Units/volume] in Serum

204

2442

0.83

1.88

1.8

1.7

6.59

7.07

iu/ml

0.12

573

(3008898) HLA-B27 [Presence]

105

1352

0.77

1.88

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.18

1.88

1.0

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

121

1.82

1.87

1.5

1.2

1.37

1.35

mmol/l

0.03

(3006922) Hepatitis E virus Ab [Presence] in Serum

349

1.46

1.86

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.86

1.86

1.1

1.6

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

269

1.53

1.83

1.5

1.3

30.85

19.82

umol/l

1.13

244

(3017446) Testosterone [Moles/volume] in Serum or Plasma

447

3966

1.14

1.83

2.2

11.56

15.01

nmol/l

13.50

396

3545

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

4.17

1.82

5.4

1.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

331

3793

0.87

1.81

2.4

2.5

27.55

22.24

au/ml

0.42

301

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

912

0.73

1.79

1.2

0.58

0.63

ratio

0.34

157

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

470

1.39

1.78

1.1

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.17

1.77

1.1

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

171

2061

0.83

1.72

1.6

1.5

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

2.92

1.72

6.9

7.0

13.14

9.00

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

2.92

1.72

3.4

3.5

22.57

48.46

—

(3044941) Cell count panel - Synovial fluid

104

1322

0.78

1.71

1.4

—

(3019150) Specific gravity of Urine by Refractometry

1462

15475

0.93

1.70

4.5

1.02

1.22

kg/l

0.81

1067

10204

(40759836) Histone Ab [Presence] in Serum by Immunoblot

456

0.63

1.68

1.1

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

124

993

1.25

1.67

1.1

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

478

0.65

1.65

1.3

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

875

8098

1.09

1.65

4.9

5.5

33.38

33.31

0.07

548

5266

(3014271) Vancomycin [Susceptibility]

443

1.38

1.65

3.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

606

0.69

1.61

1.2

7.94

7.70

mmol/l

0.19

504

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

120

1.75

1.61

1.7

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

350

0.60

1.57

1.2

1.4

141.76

193.35

pmol/l

0.88

350

(3011397) Hemoglobin [Presence] in Urine by Test strip

1685

16023

1.07

1.56

3.8

4.1

0.16

0.21

0.14

208

(3042010) Triglyceride [Moles/volume] in Pleural fluid

1.85

1.55

1.5

1.2

2.65

0.97

mmol/l

0.50

(4268621) Lupus anticoagulant assay

500

1.34

1.55

2.1

2.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

666

1.29

1.54

1.1

1.2

112.85

115.48

0.34

597

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.97

1.53

1.9

1.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

538

0.69

1.50

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

127

1036

1.23

1.48

1.3

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

312

2750

1.14

1.47

1.1

8.49

1.18

u/ml

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2050

19648

1.06

1.46

4.7

4.1

22.57

24.62

8.22

1111

9883

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

250

2171

1.16

1.46

1.5

1.6

33.35

23.54

u/ml

0.49

410

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

101

1259

0.80

1.46

1.3

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

523

1.32

1.45

1.0

1.1

6.75

3.71

eliau/ml

0.34

181

(4212803) Bone marrow aspirate examination

2.37

1.45

1.1

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

158

1321

1.20

1.45

1.2

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

252

1.47

1.44

1.1

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

140

1.64

1.44

1.3

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

700

1.27

1.43

1.3

1.4

156.40

158.93

au/ml

0.06

231

(21494755) Public health laboratory ask at order entry panel

226

2610

0.86

1.43

1.4

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.04

1.43

1.2

1.9

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

728

1.27

1.41

1.2

5.15

3.16

u/ml

0.41

254

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

109

881

1.24

1.40

2.2

2.3

35.70

24.39

mg/l

1.16

300

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

712

1.27

1.39

1.2

2.70

4.76

u/ml

1.57

327

(3029396) Erythrocyte agglutination [Presence] in Blood

2.41

1.39

2.4

1.9

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

237

2060

1.16

1.38

2.8

1.5

0.01

0.00

g/l

0.69

211

1802

(3002619) Bacteria identified in Specimen by Culture

142

1.62

1.38

1.3

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

408

0.66

1.36

1.1

—

(3004775) Volume in Urine collected for unspecified duration

573

1.29

1.36

2.3

758.83

638.45

0.88

387

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.83

1.35

1.2

102.60

132.99

ng/l

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

151

1.59

1.34

1.0

1.3

0.34

0.31

mmol/l

—

(4211845) Urine protein measurement

332

1.39

1.34

4.0

3.2

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

463

5087

0.90

1.33

1.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

149

1251

1.19

1.33

1.1

6.78

11.07

eliau/ml

0.48

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5356

54338

0.95

1.33

4.2

4.7

1.33

1.27

mmol/l

7.70

4775

49182

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

105

1.72

1.32

1.3

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

291

1.41

1.31

1.3

1.5

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

295

0.61

1.30

1.2

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

250

1.44

1.30

1.0

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4447

45321

0.95

1.30

4.1

4.2

15.06

15.03

pmol/l

0.32

3991

40928

(1002224) Polysomnography panel

166

1945

0.85

1.29

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.35

1.29

1.1

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

145

1.59

1.28

1.7

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

145

1714

0.84

1.26

1.8

1.6

1.18

1.19

g/l

0.02

139

1619

(3047189) Immunofixation for 24 hour Urine

227

1.46

1.25

1.6

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.74

1.24

1.3

1.2

41.63

115.03

ug/l

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

700

1.25

1.20

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

727

1.24

1.20

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

132

1.59

1.20

1.0

1.1

85.42

85.76

0.01

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

144

0.49

1.20

1.3

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

221

1939

1.14

1.17

2.9

1.5

0.00

g/l

-0.00

211

1797

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

141

1.56

1.16

1.3

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.77

1.16

1.1

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

193

2213

0.87

1.16

1.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5767

58302

0.95

1.10

5.7

6.5

2.52

2.55

mmol/l

1.88

5209

53735

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.26

1.10

1.1

1.2

4071.57

1874.86

ng/l

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

144

1676

0.86

1.08

1.8

1.6

0.23

g/l

0.30

138

1585

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.71

1.05

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

215

0.60

1.02

1.3

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

215

0.60

1.02

1.5

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

165

1891

0.87

1.02

1.6

17053.39

14332.15

e6/l

0.35

120

1328

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.89

1.01

1.3

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

110

1298

0.84

0.99

1.3

1.4

19.22

26.92

e6/l

0.26

984

(3029634) Reagin Ab [Titer] in Serum by VDRL

596

0.77

0.99

1.8

2.0

—

5.79

—

(3024869) Neuronal Ab [Presence] in Serum

107

1.59

0.99

1.0

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

157

1365

1.15

0.99

1.1

1.2

425.71

373.09

titre

—

115

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

177

2012

0.88

0.98

1.6

1.7

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

213

1892

1.13

0.98

1.5

5.63

18.42

iu/ml

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

271

2443

1.11

0.97

1.7

1.8

39.47

39.13

u/l

0.10

242

2078

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.97

0.0

9.6

—

148.73

—

(3040151) Glucose [Moles/volume] in Capillary blood

101

849

1.19

0.96

8.5

15.2

7.47

7.48

mmol/l

0.01

696

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.74

0.96

1.0

1.6

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.65

0.94

1.1

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

320

1.31

0.94

1.5

1.4

0.23

0.26

nmol/l

0.18

241

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

589

1.22

0.92

1.1

1.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

134

1.49

0.91

1.1

80.64

85.95

0.22

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

939

0.83

0.90

1.4

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

113

1317

0.86

0.90

1.3

1.4

265.55

1260.65

e6/l

3.29

1067

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

672

1.21

0.90

4.2

3.8

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

271

1.33

0.88

2.2

1.1

39.58

39.70

g/l

0.04

271

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

4720

46533

1.04

0.88

42.1

21.8

328.43

331.76

g/l

99.06

4696

46243

(3027923) C peptide [Moles/volume] in Serum or Plasma

386

1.27

0.87

1.2

1.3

1.17

1.21

nmol/l

0.11

276

(3034988) Calcium [Moles/volume] in Capillary blood

131

0.53

0.87

1.6

1.9

1.17

1.18

mmol/l

—

126

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.00

0.87

1.8

1.9

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

166

1466

1.14

0.86

1.6

1.9

12.86

12.10

mg/l

0.50

154

1358

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

351

1.28

0.86

2.2

2.1

30.10

194.82

ug/min

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

120

1.50

0.85

1.3

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

145

1.45

0.84

1.2

1.3

2.06

3.21

umol/l

1.81

124

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.94

0.84

1.0

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

154

1743

0.88

0.84

1.2

35.86

47.75

u/ml

—

(3044927) Protein electrophoresis panel - Urine

798

1.18

0.83

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

166

0.60

0.83

1.6

1.2

—

(3036525) Urea [Moles/time] in 24 hour Urine

1.74

0.82

3.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.69

0.82

3.0

1.5

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.79

0.0

1.0

—

(3004451) EKG impression Narrative

446

1.23

0.79

1.3

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

21.25

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

31.69

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.00

0.78

0.0

1.2

—

266.65

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

613

6486

0.94

0.78

1.3

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.59

0.78

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

0.00

0.76

0.0

1.1

—

0.22

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.00

0.76

0.0

1.6

—

0.83

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

302

0.73

0.75

1.0

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

482

0.79

0.75

1.6

1.8

135.36

112.45

ng/l

0.47

482

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

158

1.39

0.74

1.1

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.84

0.73

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.61

0.72

1.6

1.7

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

728

6931

1.06

0.71

2.3

2.5

5.32

7.80

ug/l

3.83

619

5989

(44816559) Phosphatidylethanol [Mass/volume] in Blood

185

2043

0.90

0.70

1.5

0.38

0.31

mg/l

0.68

907

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

610

1.18

0.69

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

564

1.19

0.69

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

169

0.65

0.68

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.53

0.68

2.5

2.8

0.85

0.55

u/field

0.36

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.67

0.68

1.9

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

161

1.37

0.68

1.0

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

410

1.22

0.67

1.3

1.8

89.44

92.21

umol/l

0.17

410

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

147

1640

0.89

0.67

1.2

1.3

2.89

5.20

u/ml

1.68

241

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

320

1.25

0.67

3.0

2.3

41.81

31.92

iu/ml

—

(44806420) Estimation of glomerular filtration rate

511

1.20

0.67

2.2

2.7

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.79

0.66

1.0

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

277

1.26

0.65

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

109

961

1.14

0.64

1.2

—

0.74

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

727

1.16

0.64

1.3

1.2

315.31

279.11

u/ml

0.40

447

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

315

0.76

0.64

1.7

1.5

741.55

952.48

mu/l

0.64

254

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.72

0.64

4.0

2.7

—

(3008295) Osmolality of Serum or Plasma

690

1.16

0.63

1.2

1.4

276.75

275.83

mosm/kgh2o

0.12

505

(3038177) Helicobacter pylori Ab [Presence] in Serum

812

1.15

0.63

1.3

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

234

0.73

0.62

1.3

1.2

0.65

0.51

ratio

0.41

150

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

173

1.33

0.61

1.2

11.56

11.70

pmol/l

0.01

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.67

0.61

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.60

0.0

1.1

—

8.27

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

148

1636

0.90

0.60

1.2

4.44

6.58

u/ml

0.31

159

(3043238) Trisomy 21 risk [Likelihood] in Fetus

151

0.66

0.59

1.8

1.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

971

0.87

0.59

1.7

1.6

—

(4024509) Urine culture

315

3367

0.93

0.59

2.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

260

2799

0.93

0.59

1.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

281

1.25

0.59

1.4

1.2

72.33

85.43

—

(3000034) Microalbumin [Mass/volume] in Urine

658

1.16

0.59

3.4

3.0

55.69

33.88

mg/l

0.29

485

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

138

1529

0.90

0.58

1.6

1.9

41.35

44.64

nmol/l

1.14

133

1471

(4133840) Spirometry

114

1.40

0.58

1.3

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

703

0.85

0.58

1.4

1.7

17.89

24.93

u/ml

—

162

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.58

0.0

1.1

—

0.08

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.58

0.0

1.0

—

11.16

—

(3016018) Differential panel - Cerebral spinal fluid

603

1.16

0.58

1.3

—

(3006653) Thiamine [Moles/volume] in Blood

300

1.23

0.58

1.0

1.1

128.84

135.08

nmol/l

0.25

300

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

1.46

0.57

1.0

1.1

6.38

6.61

u/ml

—

(3023410) Appearance of Cerebral spinal fluid

520

1.17

0.57

1.5

1.4

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1.71

0.57

1.0

1.2

43.17

30.92

nmol/l

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

266

2475

1.08

0.57

1.2

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.48

0.57

1.1

1.2

—

(3012516) Albumin [Mass/volume] in Urine

2380

24265

0.97

0.57

3.6

3.5

61.59

48.34

mg/l

1.78

1633

15716

(4195642) Thrombophilia screening test

670

1.15

0.56

1.1

1.2

—

(3016750) Collection duration of Urine

392

1.20

0.56

2.6

2.1

503.78

500.75

min

0.08

296

(3026389) Candida sp identified in Specimen by Organism specific culture

833

1.13

0.54

1.3

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

338

3181

1.07

0.53

3.0

3.1

4.27

4.40

pmol/l

1.84

297

2771

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

117

1298

0.90

0.53

1.3

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

226

0.75

0.52

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

226

0.75

0.52

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

226

0.75

0.52

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

226

0.75

0.52

1.1

—

(40757373) Influenza virus identified in Isolate

132

0.68

0.51

1.2

1.5

—

(3020491) Glucose [Moles/volume] in Blood

446

0.83

0.51

1.8

2.3

7.89

7.04

mmol/l

0.68

301

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

111

1232

0.90

0.51

1.1

4.32

3.25

—

105

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.38

0.50

1.1

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

145

0.69

0.50

1.6

1.5

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

1.41

0.50

1.1

1.2

82.20

74.28

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

423

0.83

0.50

1.2

1.3

0.16

1.03

u/ml

2.65

261

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

346

0.81

0.49

2.0

1.4

4.99

6.01

u/l

1.50

294

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.49

0.49

1.3

1.1

55.34

58.95

u/ml

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

380

1.19

0.49

1.0

—

(3020650) Glucose [Presence] in Urine

171

1.29

0.49

1.3

1.7

0.00

0.07

estimate

1.35

171

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

109

1207

0.90

0.49

1.6

1.9

192.27

200.14

pmol/l

0.43

104

1129

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

107

0.65

0.48

1.7

1.5

63.67

51.76

ug/l

—

107

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

808

8362

0.96

0.48

11.1

7.6

—

(3036048) Francisella tularensis Ab [Titer] in Serum

110

0.64

0.48

1.0

1.2

—

352.00

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

308

1.20

0.47

2.2

2.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.49

0.47

1.4

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.49

0.47

1.4

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.49

0.47

1.4

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

852

1.12

0.47

1.4

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

327

1.19

0.47

1.2

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

402

1.17

0.46

2.4

2.3

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

176

0.74

0.46

1.5

0.86

1.19

ratio

—

106

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

176

0.74

0.46

1.5

0.97

0.95

ratio

—

106

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

176

0.74

0.46

1.5

1.15

1.19

ratio

—

106

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

119

0.67

0.45

1.3

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

716

0.88

0.45

1.1

8.78

24.20

au/ml

—

119

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

685

1.13

0.44

1.2

40.60

36.35

u/ml

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

175

0.74

0.44

1.5

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

894

1.11

0.44

1.8

1.6

0.97

0.85

g/l

0.47

689

(3023430) Cat dander IgE Ab [Units/volume] in Serum

404

1.16

0.44

1.0

1.1

4.10

2.78

u/ml

0.32

168

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

263

0.80

0.43

1.7

1.8

112.22

125.95

umol/l

—

142

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.41

0.43

1.0

1.1

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

887

1.11

0.42

1.7

1.5

62.94

60.55

0.24

563

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

158

1.27

0.41

1.1

—

(3011985) Renin [Units/volume] in Plasma

889

1.10

0.41

1.3

65.71

64.89

mu/l

0.01

798

(3033086) Enterovirus Ab [Titer] in Serum

0.00

0.41

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.41

0.0

1.0

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

130

1411

0.92

0.41

1.2

1.99

5.90

u/ml

1.07

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.41

0.0

4.4

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.41

0.0

1.3

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.00

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

314

1.18

0.40

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.40

0.0

1.1

—

29.14

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.40

0.0

1.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

136

1255

1.09

0.40

1.4

1.5

0.87

0.84

nmol/l

0.29

120

1046

(40761535) Cells panel - Urine sediment

528

5480

0.96

0.39

3.7

3.4

—

2.17

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.43

0.39

1.0

1.52

8.19

u/ml

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

791

0.90

0.38

1.8

1.7

—

(3006576) Bicarbonate [Moles/volume] in Blood

242

1.20

0.38

4.7

6.4

24.80

25.07

mmol/l

0.07

218

(3023323) Follitropin [Units/volume] in Serum or Plasma

104

952

1.09

0.38

1.3

36.94

32.05

iu/l

0.60

817

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

472

0.87

0.37

1.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

1.35

0.37

1.0

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

158

0.76

0.37

6.2

6.3

8.57

8.71

mmol/l

0.08

158

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

152

1.25

0.36

2.7

2.5

7.62

7.75

mmol/l

0.05

(3024666) Lithium [Moles/volume] in Serum or Plasma

191

0.78

0.36

7.3

13.5

0.76

0.67

mmol/l

0.59

175

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.27

0.36

1.1

—

(3007916) DNA double strand Ab [Titer] in Serum

0.66

0.35

1.0

1.2

—

86.98

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.33

0.35

1.2

1.1

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

0.63

0.35

1.2

1.5

6421.80

734.25

mu/l

—

(3028433) Virus identified in Specimen by Culture

162

1.23

0.35

1.2

1.1

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

0.62

0.35

1.2

1.5

74.40

71.27

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

168

1790

0.94

0.35

1.5

4.09

5.35

iu/ml

0.10

369

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

301

1.16

0.34

1.1

1.0

—

(4146454) Self-monitoring of blood glucose

852

1.09

0.34

2.5

2.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

461

1.13

0.34

1.1

1.3

1.02

1.11

promille

0.20

351

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

833

1.09

0.34

1.1

1.3

251.67

286.00

pmol/l

0.79

687

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

189

0.79

0.34

1.1

1.2

22.78

35.12

—

121

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

500

0.88

0.34

1.6

1.8

—

1561.90

—

(3023419) Bacteria identified in Sputum by Culture

891

1.09

0.34

3.1

2.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

190

1792

1.06

0.33

2.4

2.3

106.67

108.90

ug/min

0.02

106

1040

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

246

1.18

0.33

1.9

56.16

50.14

ug/l

0.43

239

(3009445) Proteinase 3 Ab [Units/volume] in Serum

302

2886

1.05

0.33

1.5

17.00

20.48

iu/ml

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

133

0.75

0.33

1.8

1.9

10.18

9.07

mg/l

—

105

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

210

0.81

0.33

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

199

0.80

0.33

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

498

0.88

0.32

1.2

1.1

—

(3017704) Immunofixation for Urine

388

1.13

0.32

1.5

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

819

0.91

0.30

1.1

1.2

121.48

221.08

miu/ml

2.18

314

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

184

1.20

0.30

4.5

7.8

5.49

5.98

kpa

1.28

161

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

568

0.90

0.30

1.1

—

1.06

—

(3022621) pH of Urine by Test strip

534

5180

1.03

0.30

3.0

2.9

6.03

6.04

0.13

390

3656

(3025549) Creatine [Moles/time] in 24 hour Urine

1.27

0.30

1.3

1.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

148

1.22

0.29

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.23

0.29

1.1

1.2

1.61

1.74

umol/24h

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

270

0.85

0.28

1.2

1.3

—

(3009508) Creatinine [Moles/volume] in Urine

2440

24671

0.98

0.28

3.5

7.37

7.22

mmol/l

1.00

2025

20636

(3014891) Appearance of Pleural fluid

112

1.25

0.28

1.8

1.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

140

1.21

0.27

1.8

2.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

566

5814

0.97

0.27

1.3

1.4

—

(3025577) Chromium [Mass/volume] in Blood

511

0.90

0.27

2.1

2.11

2.20

ug/l

0.09

424

(3033923) Metanephrine [Moles/time] in 24 hour Urine

131

1.22

0.27

1.1

0.70

0.64

umol/24h

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.23

0.27

9.6

5.8

41.25

41.22

ug/min

—

(3023511) Choriogonadotropin [Units/volume] in Urine

204

0.83

0.26

1.8

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

137

1450

0.94

0.26

1.7

1.9

5.30

8.15

iu/l

0.28

538

(3020682) Albumin/Creatinine [Ratio] in Urine

2455

24805

0.98

0.26

4.3

4.2

10.79

8.68

mg/mmol

1.19

1614

15547

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

842

0.93

0.26

1.1

9580.51

558.46

iu/ml

0.45

156

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.69

0.26

1.0

1.1

91.68

38.83

iu/ml

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

367

1.12

0.25

1.0

1.1

0.55

0.28

u/ml

0.21

126

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.22

0.25

2.1

1.7

44.11

47.11

umol/l

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

466

0.90

0.25

1.0

1.2

80.00

161.27

titre

—

(3003740) Influenza virus B Ag [Presence] in Specimen

549

0.91

0.24

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

549

0.91

0.24

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

142

1.20

0.24

1.7

2.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.25

0.24

1.0

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

111

1045

1.06

0.24

1.6

1.9

4.78

4.74

mmol/24h

0.04

904

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.73

0.24

1.0

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

295

3052

0.96

0.23

1.1

1.2

99.66

125.18

u/ml

0.68

1120

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

599

0.92

0.23

1.3

70.00

547.83

titre

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

701

0.93

0.22

1.2

1.1

0.41

1.31

u/ml

3.07

388

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.77

0.22

9.0

12.2

7.77

4.94

mmol/l

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.27

0.22

1.5

1.7

—

(3024263) Appearance of Synovial fluid

333

1.11

0.22

1.7

1.6

—

(3028707) Methadone [Presence] in Urine by Screen method

326

0.89

0.22

1.7

1.8

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

603

1.08

0.21

1.2

1.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

229

1.14

0.21

2.6

2.9

33.07

28.67

umol/l

1.25

167

(3019174) dRVVT (LA screen)

1.19

0.21

1.0

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

84.10

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.9

—

243.30

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

1350.00

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

946

0.94

0.21

1.8

—

(21491868) Cryoglobulin [Mass/volume] in Serum

188

0.85

0.21

1.4

1.2

—

0.15

g/l

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.2

—

3.67

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.21

0.0

1.5

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.4

—

1.45

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

293

0.89

0.20

1.1

18.48

11.02

iu/ml

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

615

0.93

0.20

1.3

—

(3028717) Thiamine [Mass/volume] in Blood

1.25

0.20

1.0

1.1

59.80

67.53

ug/l

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

240

0.87

0.20

1.0

1.1

3.10

1.12

u/l

—

101

(3015076) Soybean IgE Ab [Units/volume] in Serum

136

1.18

0.20

1.1

1.0

0.39

0.28

u/ml

—

(4198724) Urine methamphetamine measurement

112

0.80

0.20

1.4

1.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

891

0.94

0.19

1.9

287.43

299.91

mu/l

0.11

816

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

541

0.92

0.19

1.1

—

46.37

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

210

2026

1.04

0.19

1.4

—

(40762887) Creatinine [Moles/volume] in Blood

1.18

0.19

1.8

1.7

—

(3028300) Cannabinoids [Presence] in Urine

695

0.93

0.19

1.5

1.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

357

1.09

0.18

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

128

1.17

0.18

1.3

1.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

100

1.20

0.18

2.2

1.8

32.17

26.27

0.45

(3051387) C reactive protein [Mass/volume] in Capillary blood

151

1451

1.04

0.17

3.9

3.7

34.27

28.20

mg/l

1.02

104

1046

(3004616) Nuclear Ab [Presence] in Serum

806

1.06

0.17

1.2

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.11

0.16

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

360

1.08

0.16

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

216

1.11

0.15

1.3

1.2

—

(3042733) HLA Ab [Presence] in Serum

150

0.87

0.14

2.8

4.8

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.08

0.14

2.6

0.60

0.61

ug/l

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5729

57143

1.01

0.14

5.5

5.8

6.16

6.09

mmol/l

3.76

5192

51802

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

160

1.13

0.14

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

490

0.94

0.13

1.3

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

345

1.07

0.12

3.9

4.3

—

(3021788) Differential panel - Synovial fluid

132

1362

0.97

0.12

1.5

—

1.00

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

158

0.89

0.12

1.6

1.5

9.49

9.71

ug/l

0.09

158

(3027008) Opiates [Presence] in Urine

689

0.96

0.11

1.5

1.6

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

556

0.95

0.10

1.1

1.10

0.80

u/ml

0.17

229

(3000285) Sodium [Moles/volume] in Blood

177

0.90

0.10

1.3

1.2

137.94

138.67

mmol/l

0.22

152

(3000764) Benzodiazepines [Presence] in Urine

688

0.96

0.10

1.5

1.7

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

268

0.93

0.09

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

237

0.93

0.09

1.0

1.1

1737.95

1716.09

miu/ml

0.03

237

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.83

0.08

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.79

0.08

1.2

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.78

0.08

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

696

1.03

0.08

1.6

1.4

106619.89

190654.18

e6/l

0.48

474

(3001019) Free T4 and TSH panel - Serum or Plasma

150

1532

0.98

0.08

1.7

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.09

0.08

1.0

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.08

0.08

4.6

5.3

—

28282.00

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

156

1.09

0.08

1.2

13.53

11.08

mm/h

0.26

156

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

156

1.09

0.08

1.1

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.07

0.07

1.1

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

108

1.11

0.07

1.2

1.1

—

(3018133) Calcium [Moles/volume] in Urine

1.05

0.07

1.8

1.6

2.11

2.70

mmol/l

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

214

0.93

0.07

3.6

6.1

63.36

70.40

0.44

177

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

132

0.91

0.06

4.0

7.3

10.67

10.20

0.33

132

(3013139) Helicobacter pylori Ag [Presence] in Stool

418

4141

1.01

0.06

1.2

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

131

0.92

0.05

1.7

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

563

1.03

0.05

1.7

1.4

7.34

6.88

g/l

0.44

405

(3024139) IgG subclass 3 [Mass/volume] in Serum

563

1.03

0.05

1.7

1.4

0.51

0.41

g/l

0.73

409

(3028192) IgG subclass 2 [Mass/volume] in Serum

563

1.03

0.05

1.7

1.4

3.11

2.96

g/l

0.27

404

(3033099) Centromere Ab [Titer] in Serum

139

1.08

0.05

1.0

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

120

0.92

0.05

1.1

—

(3025130) Human papilloma virus identified in Specimen

434

0.97

0.05

1.3

1.8

—

(3034891) Synovial lining cells/cells in Synovial fluid

343

0.96

0.04

1.6

1.5

1.00

4.26

—

(3002079) Sodium [Moles/time] in 24 hour Urine

272

0.96

0.04

1.1

1.2

150.35

166.24

mmol/24h

0.44

272

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

250

2521

0.99

0.04

1.0

1.1

—

(3027944) Amphetamines [Presence] in Urine

683

0.98

0.03

1.4

1.6

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

161

1.06

0.03

4.3

7.8

6.11

5.16

kpa

0.62

161

(3016879) Cocaine [Presence] in Urine

638

1.02

0.03

1.5

1.7

—

(4062490) Immunoglobulin typing, IgG

551

0.98

0.03

1.7

1.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5450

54457

1.00

0.02

5.1

5.4

2.02

mu/l

0.04

4904

49660

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

148

0.95

0.02

1.6

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

172

1.05

0.02

1.1

96.00

94.05

0.08

133

(3020961) Endomysium IgA Ab [Titer] in Serum

233

2344

0.99

0.02

1.1

151.00

168.50

titre

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

441

1.02

0.02

1.0

1.1

4.54

2.46

u/ml

0.42

218

(3003888) Timothy IgE Ab [Units/volume] in Serum

571

1.02

0.02

1.1

5.15

3.19

u/ml

0.28

276

(3001964) Herpes simplex virus Ag [Presence] in Specimen

127

0.94

0.01

1.0

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

123

1.06

0.01

1.0

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

167

0.96

0.01

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

163

1.04

0.01

1.6

1.5

83.65

71.75

nmol/24h

0.53

163

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

207

0.97

0.01

1.2

1.3

93.16

149.63

nmol/l

2.01

147

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

164

1.04

0.00

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

256

1.02

0.00

1.2

1.1

1.07

ratio

0.00

210

(3024471) HLA-A [Type]

112

0.98

0.00

1.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

241

1.00

0.00

1.2

39.25

40.12

g/l

0.09

113

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

219

1.00

0.00

1.2

1.1

20.72

21.97

u/ml

0.07

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

265

1.02

0.00

1.2

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

666

1.01

0.00

1.6

1.5

28.60

28.94

0.03

434

(40768446) Kidney Pathology biopsy report

199

1.00

0.00

1.5

1.6

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

169

1.01

0.00

1.1

1.0

1.78

0.86

u/ml

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

167

1.02

0.00

1.1

1.4

1.18

1.17

mmol/l

0.08

167

(3024932) HLA-DR beta [Type]

110

1.00

0.00

1.0

—

(3034426) Prothrombin time (PT)

155

1.03

0.00

1.1

1.2

28.19

28.64

0.05

155

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

230

1.00

0.00

1.1

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

187

1.02

0.00

1.1

—

(4015189) Microbial culture of sputum

203

0.98

0.00

1.8

2.5

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

174

0.98

0.00

1.6

1.5

0.29

0.38

ug/l

0.39

107

(3037692) Legionella sp identified in Specimen by Organism specific culture

174

0.98

0.00

1.2

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

376

1.01

0.00

1.2

1.0

8.13

8.77

nmol/l

0.04

(1001926) Buprenorphine [Presence] in Urine by Screen method

524

0.99

0.00

1.5

1.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

496

1.01

0.00

1.1

0.48

1.14

u/ml

1.24

244

(3020874) Milk IgE Ab [Units/volume] in Serum

183

0.98

0.00

1.1

1.0

0.64

1.42

u/ml

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

2.1

—

1.93

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

11.31

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

35.64

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

7.3

—

0.24

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

-0.00

0.0

1.1

—

2.71

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.03

—

(44806071) Cardiolipin IgM antibody measurement

0.85

-0.00

1.0

1.1

—

(3025504) Homovanillate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.8

—

28.90

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.2

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

-0.00

0.0

1.2

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

3871.43

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

93.00

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3016135) IgD [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

36.33

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.94

-0.00

2.0

1.7

—

0.75

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

121.40

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_COLON – Malignant neoplasm of colon

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of colon

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of colon (C3_COLON)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints